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T-cells are central to our success as a species. They confer specific and long-term immunity in a 
process known as adaptive immunity. During adaptive immune response, pathogen ingested by 
peripheral sentinel cells are brought to the local lymph nodes and presented to T-cells. T-cell 
recognizes the antigen via its receptor complex (TCR-CD3). The high affinity binding primes the 
cell for activation. With a positive costimulationary signal from CD28, the T-cell is fully 
activated, resulting in IL-2 secretions and cellular proliferation. Clinicians are increasingly 
harnessing the adaptive immune system to combat diseases such as cancer. Specifically, T-cells 
are activated and expanded ex vivo for adoptive immunotherapies. The ability to modulate T-
cell activation is crucial in engineering appropriate effector cell populations for therapeutics. 
The focus of this thesis is to address the functional impact of CD28 spatial organization on T-cell 
activation. 
It has been observed that the spatial segregation of CD3 and CD28 by a few microns has 
resulted in poor activation of human T-cells. Lck, a Src family kinase (SFK) emerges as the 
instigator of the phenomenon. The kinase is associated with both CD3 and CD28 signal 
cascades. We propose a reaction diffusion model to describe the delicate balance between 
protein mobility and Lck de-activation. The work in this dissertation describes two probes to 
investigate Lck kinase activity, which permit real-time imaging of both the initiation of pLck 
activity and its duration. A FRET reporter is constructed to study the spatial and temporal 
initiation of the kinase activity. Embedded with the Lck membrane domain and contained a 
substrate for pLck to phosphorylate, the FRET biosensor reports the Lck kinase activity in real-
time. Using microprinting to control CD3 and CD28 spatial organizations, the FRET reporter 
reveals that while T-cells require CD28 for significant IL-2 secretion, CD3 engagement is 
essential to initiate cellular activation through a spike in pLck kinase activity. Spatially, the 
reporter shows heightened kinase activity concentrated at the center of the cells upon CD3 
engagement.  
To study the duration of pLck activity, a recruitment reporter is made. CD3 is found ubiquitously 
throughout the cellular membrane. And its activation by pLck induces the recruitment of a pair 
of tandem SH2-domain. The recruitment probe (also containing a pair of tandem SH2-domain) 
revealed curtailed pLck kinase activity due to CD3-CD28 segregation. Ultimately, understanding 
CD28 modulation of T-cell activation is clinically relevant as it provides new opportunities and 
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Figure 1.1: Primary adaptive immunity response initiates a week after primary infection. It is a 
specific defense with memory. Years after the primary infection, exposure to the same 
pathogen results in an accelerated and more robust immune response. Adapted from 
(Parham and Janeway 2009).  
Figure 1.2: T helper cell traditional lineages. 5 well-characterized lineages are Th1, Th2, Th17, 
Treg, and Tfh. Th1 defends against intracellular parasites. Th2 controls parasites and 
extracellular pathogens; negatively, it is associated with allergy and asthma. Th17 is 
most known for its destructive effects: autoimmunity, cancer, and transplantation 
rejection. Treg participates in immune homeostasis and maintains tolerance.  Finally Tfh 
found in B-cell follicles of secondary lymphoid organs aids in B-cell antibody production. 
Adapted from (Sethi, Kulkarni et al. 2013). 
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Figure 1.3: Plasticity of T-cell differentiation. The ability of T-cell lineages to be reconditioned 
has important implications for immunotherapeutics.  From (Zhou, Chong et al. 2009). 
Figure 1.4: MHC-TCR-independent activation of engineered T-cells achieved with antibody 
receptor genetically engineered against a target antigen. The receptor is then coupled 
to a signaling domain intracellularly. Adapted from (Maus, Grupp et al. 2014) and 
(Restifo, Dudley et al. 2012).  
Figure 1.5: A. Immunological synapse is the site of critical ligand interactions. T-cells are primed 
when TCRs recognize specific peptide-loaded MHC. Then costimulatory signal is given by 
APC via its binding to either CD28 or CTLA-4 receptors. The signaling structure is further 
stabilized by adhesive receptor LFA-1, which binds to ICAM-1 on APCs. From (Abbas, 
Lichtman et al. 2007). B. The high sensitivity of T-cell recognition is made possible by the 
formation of spatially discrete zones within the SMAC. Adapted from (Dustin, 
Chakraborty et al. 2010). 
Figure 1.6: The effect of CD80 on TCR spatial organization. A. The APC presents only MHC-II and 
LFA-1. CD80 is necessary for TCR migration to the cSMAC. Its absence results in loss of 
spatial segregation as TCR (red) mixes with LFA-1 (blue). B. With full-length CD80, one 
observes segregation of CD80FL from TCR clusters. C. With tail deleted CD80, CD80TL 
colocalizes with TCR. Scale bar = 2µm. From (Tseng, Liu et al. 2005) 
Figure 1.7: A. Mouse T-cells respond robustly to peripheral presentation of CD28. From (Shen, 
Thomas et al. 2008). B. Human T-cells respond most potently to colocalized presentation 
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of CD3 and CD28, and also peripheral presentation of the proteins. From (Bashour, Tsai 
et al. 2014).   
Figure 1.8: A. Well established is the role of pLck in TCR/CD3 complex-associated signaling. Lck 
phosphorylates ITAMs on CD3. Then pITAMs act as docking sites for ZAP70 by 
interacting with the ZAP70 SH2 domains. ZAP70 initiates a network of signaling proteins 
with diverse functions. Adapted from (Koretzky and Myung 2001). B. Less understood is 
the role of pLck in CD28-associated signaling. Two signaling pathways have been 
discovered for CD28. One is a PI3K (the p86-p110 heterodimer)-dependent pathway, 
and another is an adaptor protein (Grb2 or GADS)-dependent pathway. Suspect of 
phosphorylating the YMNM motifs on CD28, Lck is known also to activate PDK1. 
Adapted from (Boomer and Green 2010). 
Figure 1.9: A. Stainings in mouse T-cells revealed pLck to be localized throughout the interface, 
regardless of the patterned surfaces. From (Bashour, Tsai et al. 2014). B. Human T-cell 
stainings of Lck revealed a preference for CD3, with lesser overlap on CD28. From 
(Bashour, Tsai et al. 2014). C. Translocation of Lck between TCR-CD3 complex and CD28 
to initiate signaling cascade will be a function of Lck diffusion and pLck 
dephosphorylation.  Please note: pLck staining was performed with pY394 antibody, 
which is unable to distinguish between pLck and pFyn. Thus, it’s referred to as pSFK. 
Figure 2.1: Autoinhibited kinase is characterized by the activating Y416 being buried in the 
active site cleft . This is achieved by two intramolecular interactions: pY527 binding 
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with R175  and SH2-SH3-kinase linker packing against the back of the catalytic domain
. In the activated form, pY416 pins the active site open . Adapted from (Boggon and 
Eck 2004). 
Figure 2.2:  A. Diagram of the constructs. CLckY-1 is a fully functional Lck. Y505F, having 
removed the autoinhibitory tyrosine, is the ‘open’ form. Y394F cannot be 
phosphorylated, is the ‘closed’ form. Finally ECYFP is a positive control for FRET 
response. B. Spectral emission in JCam1.6 for the four constructs. Adapted from 
(Stirnweiss, Hartig et al. 2013).  
Figure 2.3: The HindII digestion of pHR-ZIP. The enzyme digested the plasmid into eight 
fragments. The largest fragment 7758-11197 contained the ZIP reporter. And the 
second largest fragment 238-3473 had the bacterial origin of replication and ampicillin 
resistance for selection. The two pieces were recovered and religated together.  
Figure 2.4: A. Schematic of the Src FRET reporter: membrane-targeting domain 
(MGCIKSKRKDNLNDDE), donor (eCFP), SH2 domain, flexible linker, substrate, and 
acceptor (eYFP). B. FRET response upon Src activation. Adapted from (Wang, Botvinick 
et al. 2005).  
Figure 2.5: ITAMs in CD3. The motifs are well conserved between the species. Differences are 
highlighted in white. ITAM3 is identical between human and mouse. 
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Figure 2.6: A. Diagram of the ZIP reporter. It contains full-length CD3, eGFP, linker, mCherry, 
and human SH2. B. Jurkat transfected with ZIPWT, ZIPYF, and ZIPR37K/R180K; the cells 
adhered onto glass precoated with -CD3 antibody for 10min before being fixed and 
measured using TCSPC-FLIM. From (Yudushkin and Vale 2010). 
Figure 2.7: Spectra for YPET, eGFP and mCherry. YPET has a 30nm blue shift in excitation when 
compared to eGFP. Because mCherry has a wide excitation spectrum, minimal loss 
experienced in overlap with YPET. Black vertical bar denotes the excitation laser 
wavelength.  
Figure 2.8: Plasmid transfection of LckR_FRET into NIH 3T3 cells to check for out-of-frame 
mutations. Scale bar = 10µm.  
Figure 2.9: Box and whisker diagram of FRET ratio for Jurkat cells transfected with LckR_FRET. P 
< 0.05.  
Figure 3.1: A. Wortmannin inhibition of B7-2 induced PIP3 conversion was concentration 
dependent. B. Wortmannin, despite PIP3 inhibition, resulted in increased IL-2 secretion. 
From (Ueda, Levine et al. 1995). 




Figure 3.3: Representative images of transfected mouse splenocytes. Images were taken in 
Brightfield, interference reflection microscopy (IRM), and epifluorescence (for GFP). IRM 
reports cellular adhesion, a good indicator of cellular viability. Red arrows point to 
apoptotic cells. Scale Bar = 10µm. 
Figure 3.4: Representative images of transfected mouse splenocytes. Images were taken in 
Brightfield, IRM, and epifluorescence (for GFP or YPET and mCherry). Mouse 
spleenocytes tolerated GFP, but not LckR_FRET.  Scale Bar = 10µm. 
Figure 3.5: Representative images of transfected human peripheral blood CD4+ T-cells. Images 
were taken in Brightfield, IRM, and epifluorescence (for YPET and mCherry). While 
transfection was achieved at 2200mV and 3.5ug of mRNA, the cell was not viable as 
seen in IRM. Scale Bar = 10µm. 
Figure 3.6: Representative images of transfected human peripheral blood Cd4+ T-cells using the 
Amaxa system. Images were taken in Brightfield, IRM, and epifluorescence (for GFP or 
YPET and mCherry). Despite a large quantity of LckR_FRET mRNA, the transfection 
efficiency was still poor. Scale Bar = 10µm. 
Figure 3.7: A. mouse transgenic splenic T-cell were activated by APCs from B10.BR mice. From 
(Lee, Holdorf et al. 2002). B. Jurkat cells were seeded onto activating surfaces. All the 
cells are fixed at the indicated time, perforated, blocked and stained with pLck.  
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Figure 3.8: Cellular response to micropatterned surface. A. mouse splenocytes favored 
peripheral presentation of CD28. From (Shen, Thomas et al. 2008). B. Human peripheral 
blood lymphocytes favored co-presentation of CD3 and CD28. From (Bashour, Tsai et al. 
2014). C. Jurkat cells, while like human primary cells responded most strongly to COL 
surfaces, had significant IL-2 secretion on SEG patterns. 
Figure 3.9: PLck staining of mouse naïve T-cells, human primary T-cells, and Jurkat cells. While 
pLck was found throughout the mouse T-cell –glass interface, pLck preferentially co-
localize with CD3 in human primary cells. From (Bashour, Tsai et al. 2014). In human 
lymphoblastic cell line, Jurkat E6.1, pLck also favored CD3. However, there existed a low 
concentration of pLck throughout the cell-glass interface.  
Figure 3.10: Plots of a representative null cell bouncing on the glass surface. The cell is not in 
contact with any micropatterned proteins ( trace of closest micropatterned dot). 
And the FRET ratio is sensitive to cells stepping on and off the glass surface. 
Figure 3.11: A. Plots of a representative null cell landing and spreading on the glass surface. 
Again the cell is not in contact with any micropatterned proteins ( closest 
micropatterned surface). B. FRET ratio traces of null cells.  
Figure 3.12: A cell interacting intermittently with the micropatterned proteins ( CD3-dot).  
Figure 3.13: Montage of a Jurkat cell interacting with a COL micropatterned glass coverslide. A. 
Only the donor (YPET) intensity was shown. B. Heat map of FRET ratios. Scale bar = 5µm. 
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Figure 3.14: Plots of a representative cell on a SEG surface. The cell landed onto the surface. At 
around T = 5 min, it came into contact with the -CD3 dot ( ). Then the cell 
sustained the contact with a varying degree of intensities, depending on the size of the 
lamellipodia.  
Figure 3.15: The same representative cell from Fig. 3.14 on a SEG surface. The cell landed and 
began to spread. At around 10min, contact with -CD3 dot initiated centripetal 
retrograde flow. A. Montage of a Jurkat cell on SEG patterns, with green for YPET 
intensity and red for mCherry intensity. B. Heat map of FRET ratio. Scale bar = 5µm. 
Figure 3.16: FRET ratio of Jurkat cells on micropatterned surfaces: null, CD3, COL, and SEG. The 
differences were statistically insignificant.  
Figure 4.1: A. Zap70 recruitment upon Lck activation. The tandem SH2-domain are recruited to 
the pITAM. B. Schematic of Zap70 protein: tandem SH2-domain, interdomain B with 
crucial regulatory tyrosine, and kinase domains. From (Au-Yeung, Deindl et al. 2009).  
Figure 4.2: A. Zap70 recruited to TCR in tight contact with the surface, as seen in IRM imaging. 
And the recruitment occurred within 15s. B. The signal persists without moving laterally. 
From (Bunnell, Hong et al. 2002).  
Figure 4.3: A. In epifluorescence, the light source penetrates the cover slip to illuminate a field 
of view without spatial constraint. B. TIRF imaging, the beam undergoes total internal 
reflection. Some of the incident energy generate an evanescent field. Its depth is a 
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function of the differences in refractive induces of the interface, and its intensity decays 
exponentially. From (Mattheyses, Simon et al. 2010). 
Figure 4.4: Schematic of reporter redesign from a pLck FRET reporter to a Zap70 recruitment 
biosensor.  
Figure 4.5: A. SH2_YPET transfected Jurkat cell on surface completely coated with activating 
antibodies. Clusters of ZH2_YPET were laterally static. B. In contrast, SH2_YPET was very 
fluid in Jurkat cell exposed to micropatterns C. The fully coated surface was used to 
check whether SH2_YPET molecules were stably bound to pITAM. Its recovery in about 2 
minutes suggested active exchange between bleached and unbleached pools of 
SH2_YPET. Scale bar = 5µm. 
Figure 4.6: SH2_YPET distribution is unique from both pZap70 and pLck. Its distribution more 
closely resembles that of pLck than pZap70. While pZap70 has mostly disappeared 15 
minutes after seeding, pLck concentrated on the micropatterned protein dots with 
some found throughout the cell. Scale bar = 5µm. 
Figure 4.7: Null cells transfected with SH2_YPET mRNA were seeded on micropatterned 
surfaces. No intense increases in TIRF of SH2_YPET (in green) was observed beyond the 
initial cell landing and spreading. Epifluorescence of SH2_YPET (in red) remained largely 
unchanged. Scale bar = 5µm. 
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Figure 4.8: Jurkat cell transfected with LckR_FRET on α-CD3 (blue) only surface with YPET in 
green and mCherry in red. The FRET reporter was unable to detect a high concentration 
of kinase activity on the α-CD3 dot as seen in the color map.  Scale bar = 5µm. 
Figure 4.9: Jurkat cell transfected with SH2_YPET on α-CD3 (blue) only surface. When a cell only 
interacts with micropatterned surface at the lamellipodia, the recruitment ratio exhibits 
spatial distortion.  Note the gradient in epifluorescence intensity (red) as a function of 
cell radius. Scale bar = 5µm. 
Figure 4.10:  Jurkat cell transfected with SH2_YPET (TIRF intensity in green and epifluorescence 
intensity in red) on COL pattern (blue). The cell lands and spreads around the stamped 
protein. Initially, pLck was found throughout the interface, with heightened kinase 
activity on the -CD3/-CD28 dot. While pLck activity gradually dropped off across the 
interface, recruitment remained strong at the dot. A trace of averaged intensities on the 
dot was plotted. Scale bar = 5µm. 
Figure 4.11: TIRF/Epifluorescence ratio of Jurkat cells on COL surfaces.  
Figure 4.12: Jurkat cell on SEG pattern (blue for -CD28 and pink for -CD3). As previously 
discussed, the cell initiated contact with -CD3 dot and increased recruitment of 
reporter was observed near the center of the cell. Scale bar = 10µm. 
Figure 4.13: Normalized TIRF intensity of Jurkat cells on COL (in green) and SEG (in red) 
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1.1 Cancer and Personalized Medicine  
Cancer is the abnormal growth of host cells. While clinically easy to describe, the group of more 
than 100 diseases arises from complex combinations of genetic and environmental factors. In 
2011, the heterogeneous body of diseases accounts for roughly $88.7 billion in direct cost (Soni 
2014). Despite costly healthcare expenditure and substantial funding for cancer research, the 
overall rate of cancer mortality has only decreasing around 1.6% from 2002-2011 (National 
Cancer Institute 2015). In contrast, mortality rate of cardiovascular disease has decreased by 
30.8% during the same period (Mozaffarian, Benjamin et al. 2015).  
One contributing factor is the broad-brush approach to treatment. In an effort to contain the 
malignant cells, healthy host cells are sacrificed in invasive nonspecific procedures such as 
radiation, surgery, and chemotherapy. With increasing understanding of genetic and molecular 
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biological mechanisms governing malignancy, the field is exploring and investing in personalized 
treatments, in an effort to limit collateral damages to healthy cells. And most recently, clinicians 
are interested in harnessing the patient’s own immune system to combat cancerous cell in a 
treatment known as immunotherapy. 
1.2 Immune System  
Central to our success as a species has been the ability of our immune system to identify and 
defend against foreign invaders. The host resistances are multi-step, sequential, and inter-
communicating. Beyond the first lines of defense, physical barriers and intrinsic immunity, is 
the innate immunity. The system functions continuously, thus able to respond instantaneously 
to a foreign pathogen. This is achieved nonspecifically through the binding of common 
pathogenic motifs to the pattern recognition receptors (PRRs). The activation of PRRs results in 
cytokines being secreted by the infected cells to attract local sentinel cells. The sentinel cells 
initiate inflammation to disrupt pathogen expansions into healthy cells. The innate immunity is 
nonspecific and without memory: every infection is ‘new’ and the response is identical. 
In contrast, adaptive immune response is specific and long-term. Also recruited to the site of 
infection are antigen-presenting cells (APCs), critical links between innate and adaptive immune 
systems. In a week, the APCs, having ingested the microbes, migrate to the local lymph nodes. 
APCs load the pathogen fragments onto receptors to be presented to the T- and B-lymphocytes. 
The adaptive response has three distinct phases: recognition, amplification, and control 
(Janeway 2005). First, specific lymphocytes are activated for each pathogen. Then the activated 
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lymphocytes differentiate and multiply into different effector cell types to combat the 
pathogen. Finally the system reestablishes homeostasis as T-cells undergo apoptosis, leaving 
behind memory cells for swift and augmented responses during subsequent infections with the 
same pathogen (Fig. 1.1).  
 
Figure 1.1: Primary adaptive immunity response initiates a week after primary infection. It is a specific defense 
with memory. Years after the primary infection, exposure to the same pathogen results in an accelerated and 
more robust immune response. Adapted from (Parham and Janeway 2009). 
In the context of immunotherapy, much of the research focuses on the initial recognition and 
activation of T-lymphocytes. Two major subsets of T-cells exist, distinguished by its interaction 
with two classes of antigen presenting receptors, or major histocompatibility complexes 
(MHCs), on APCs. MHC class I receptors bind to CD8+ cytotoxic T lymphocytes (CTLs), which as 
the name suggests directly engage and kill pathogens. CD4+ helper T-cells, binding to MHC class 
II receptors, are the master coordinators of adaptive immunity. The CD4+ helper T-cells 
communicate through cytokine secretions and interactions with other immune cells to shape 
the effector responses.  
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1.3 CD4+ Helper T-cell 
Crucial to CD4+ T-cell coordination of an appropriate response is its plasticity to shape an 
effective defense (Fig. 1.2). Canonical T-cell effector roles include humoral and cell-mediated 
immunities. With increasing understanding of helper T-cells, more lineages have been 
identified. 
 
Figure 1.2: T helper cell traditional lineages. Five well-characterized lineages are Th1, Th2, Th17, Treg, and Tfh. 
Th1 defends against intracellular parasites. Th2 controls parasites and extracellular pathogens; negatively, it is 
associated with allergy and asthma. Th17 is most known for its destructive effects: autoimmunity, cancer, and 
transplantation rejection. Treg participates in immune homeostasis and maintains tolerance.  Finally Tfh residing 
in B-cell follicles of secondary lymphoid organs aids in B-cell antibody production. Adapted from (Sethi, Kulkarni 
et al. 2013). 
In cell-mediated immunity, CD4+ T Helper 1 (Th1) cells recruit CTLs, macrophages, neutrophils, 
and other effector cells to kill intracellular pathogens and tumor cells. In humoral immunity, 
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CD4+ T Helper 2 (Th2) cells help B-cells to produce antibody and to undergo affinity maturation. 
Th2 cells mediate an effective B-cell response against blood circulating pathogens and toxins, 
which are neutralized and marked by antibodies for phagocytosis and elimination by the 
complement system (Zhu and Paul 2010). Less understood, but known for much longer are 
Th17 cells. Interleukin-17 (IL-17) is the signature cytokine; it is highly inflammatory (Tesmer, 
Lundy et al. 2008). Believed to be important for protection against extracellular bacteria and 
some fungi before the advent of modern sanitation, Th17 is better known for its inflammatory 
effects in diverse group of autoimmune diseases such as rheumatoid arthritis, transplantation 
rejection, and cancer (Tesmer, Lundy et al. 2008). Regulatory T-cells (Tregs) suppress the 
activation and expansion of B- and T-cells that bind strongly to self-antigen through direct cell 
contact; thus disruption in Treg functions results in autoimmunity and inflammatory diseases. 
During adaptive immune response, the delicate balance between effector cells (T- and B-cells) 
and Tregs is crucial in shaping an appropriate response: a proper immune reaction of suitable 
quality and magnitude versus tolerance for self-antigens (Sakaguchi, Yamaguchi et al. 2008). 
Finally, follicular helper T (Tfh) cells are located in the secondary lymphoid organ: such as lymph 
nodes, tonsils, spleen, and Peyer's patches. Tfh regulates B-cell immunity by aiding in antibody 
production by activating affinity maturation and antibody class switching (Fazilleau, Mark et al. 
2009).  
New potential lineages are Type 1 regulatory T (Tr1) cells, T helper 3 (Th3) cells, and T Helper 9 
(Th9) cells. Tr1 cells are CD4+ T-cells that secrete predominately IL-10 and some TGF-β, both are 
immunosuppressive cytokines. IL-10 is important for immune tolerance and the dampening of 
autoimmune diseases (Pot, Apetoh et al. 2011). Th3 cells are specifically involved in mucosal 
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immunity, while secreting predominately TGF-β and some IL-10. TGF-β is important to induce 
the production of IgA; the immunoglobulin is a noninflammatory complex that’s a poor 
activator of the complement system, thus weakly phagocytosed. Th3 cells through IgA also 
suppress Th1 and Th2 cells in the mucosal surfaces (Weiner 2001). As the mucosal membrane is 
constantly being exposed to pathogens, sustained inflammation of the gut is undesirable. 
Finally, Th9 cells are defined by the secretion of IL-9, a proliferative cytokine. And it’s been 
associated with human allergic diseases such as asthma and allergic rhinitis (Soroosh and 
Doherty 2009).  
The heterogeneous population of effector and regulatory T-cells demonstrates T helper cell 
plasticity and crossover of functional roles, crucial to its ability to effectively combat a diverse 





Figure 1.3: Plasticity of T-cell differentiation. The ability of T-cell lineages to be reconditioned has important implications for 
immunotherapeutics.  From (Zhou, Chong et al. 2009). 
The ability to understand the mechanisms governing T-cell activation and differentiation is 
critical for cellular-based immunotherapy, specifically to modify and modulate host responses 
to diseases such as cancer.  
1.4 Adoptive Immunotherapy 
Clinicians, in an effort to harness the adaptive immune system to combat tumors, have 
attempted two fundamentally different strategies: therapeutic vaccination and passive 
immunization (June 2007). Initially, therapeutic vaccination was an attractive approach, trying 
to booster a patient’s reactivity to tumor cells with low toxicities. However, a review by 
Klebanoff and colleagues summarized seven years of clinical researches in the Surgery Branch 
of the National Cancer Institute. They found that in only less than 4% of patients, were the 
tumors induced to regress (Klebanoff, Acquavella et al. 2011). Three major factors contribute to 
the failure of therapeutic vaccinations. One, the tumor cells recruit Tregs and induce the 
differentiation of myeloid derived suppressor cells (MDSCs). Two, the tumor-specific T-cells are 
prone to immunological exhaustion and senescence.  In a healthy host, the intricate balance of 
immunostimulatory and immunosuppressive T-cells insure proper clonal expansion to eliminate 
pathogens and contraction to prevent autoimmunity. Contraction to homeostasis is 
reestablished by inducing cell exhaustion and apoptosis. In cancer patients, between the 
recruitment of Treg and chronic nature of the tumor-bearing state, T-cells are immunologically 
exhausted, poorly functional and weakly proliferative. Moreover, T-cells enter into senescence, 
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cell cycle arrest, and non-responsiveness (Yao and Moorman 2013). Finally, tumors are highly 
mutagenic, resulting in immune evasion (Klebanoff, Acquavella et al. 2011) 
Recent years experimental treatments with passive immunization, also known as adoptive T-
cell therapy, appear to have the potential to enhance host anti-tumor immunity. Briefly, T-cells 
are isolated (autologous or allogeneic) and expanded ex vivo before being infused into the 
patient. Three distinct strategies have been explored: CTL therapy, tumor-infiltrating 
lymphocyte (TIL) therapy, and engineered T-cells.  CTL therapy clinically has been investigated 
in melanoma patients. Infusion of CTLs specific for Melanoma-associated Antigen Recognized 
by T-cells 1 (MART-1) was effective. However, it resulted in outgrowth of MART-1–negative 
tumor masses. This illustrates one fundamental flaw with ex vivo-activated lymphocytes. 
Because lymphocytes are highly specific for an antigen, the technique permits the outgrowth of 
antigen escape variants. Instead of tumor regression, in a vaccine-like response, the tumor 
mutates and continues to expand with epitopes not recognized by the infused CTLs (June 2007). 
A possible solution is the generation of a broader repertoire of tumor-specific CTLs.  
Another strategy, recognizing the limitation of CTL therapy, is TIL therapy. Instead of ex vivo 
activation of selective antigen-specific CTLs, TIL therapy isolates diverse types of immune cells 
from tumor masses already sensitized to the cancerous cells. The ex vivo culturing of the 
immune cells remove them from the immunosuppressive microenvironment generated by both 
the tumor cells and MDSCs. In a study by Rosenberg and colleagues, metastatic melanoma 
patients underwent TIL therapy. Of the 93 patients, 20 patients were responsive: achieved 
complete tumor regression. The response was durable, with 19 patients having complete 
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regressions beyond 3 years (Rosenberg, Yang et al. 2011). However most patients were non-
responsive due to a few critical factors: telomere shortening, reduced expression of CD27+ 
CTLs, and poor persistence of TILs in circulation a month after infusion. In general, the clinical 
study illustrates one large limitation to TIL therapy: the technical difficulty of culturing TILs. 
Only 30-40% of the biopsied specimens yielded satisfactory T-cell population (June 2007). 
Lymphocyte culturing is both labor and resources intensive, requiring ~6 weeks. The lengthy 
lymphocyte culturing is associated with telomere shortening, which induces cellular 
senescence, and reduction of CD27 and CD28 in TILs, which is crucial for a robust immune 
response (Tran, Zhou et al. 2008).  
Another strategy is engineered T-cells. Depending on the types of cancer, many different 
approaches have been made to engineer T-cells. One extremely successful method has been to 
use chimeric antigen receptors (CARs), pioneered by Carl June, our clinical collaborator. The 
June group specializes in treating chronic lymphocytic leukemia (CLL). Not a solid tumor, CCL 
directly affects B-cells. The condition is life-threatening; however, people can live without their 
B-cells. Thus the June group targeted a B-cell specific marker, CD19. Using this tissue-
differentiation antigen is only possible because B-cells are not essential for life. CARs are 
constructed to bypass MHC-T-cell Receptor (MHC-TCR) engagement using a genetically 
engineered activating receptor against CD19. Intracellularly, the receptor is coupled to a TCR 
signaling domain CD3 and a costimulatory domain CD137 or CD28 (Kalos, Levine et al. 
2011)(Fig. 1.4). Clinically, the CARS therapy was administrated into both children and adult 
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patients with acute lymphoblastic leukemia (ALL) and CLL. Complete remission was achieved for 
90% of the patients with ALL (Maude, Frey et al. 2014). 
 
 
Figure 1.4: MHC-TCR-independent activation of engineered T-cells achieved with antibody receptor genetically 
engineered against a target antigen. The receptor is then coupled to a signaling domain intracellularly. Adapted 
from (Maus, Grupp et al. 2014) and (Restifo, Dudley et al. 2012). 
Our collaboration with the June group looks to improve T-cell activation and expansion before 
genetic engineering. The clinical gold-standard for cell expansion is polystyrene beads with 
magnetic cores. The bead is coated with activating antibodies and removed before infusion into 
patients. Unfortunately, the removal is imperfect, thus work in our lab explores alternative 
expansion platforms.  
1.5 T-cell Activation 
As APCs traffic into local lymph nodes, they interact with naïve T-cells. And T-cell activation is 
initiated at the immunological synapse (IS), the interface between T-cells and APCs. Specificity 
is conferred when T-cell receptors (TCR) recognize and bind to peptides loaded onto MHC-II 
receptors (pHMCs). With less than 10 specific pHMC complexes being presented on the APC 
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surface, the naïve T-cell is primed. Costimulatory signal is necessary to sustain the interaction. 
Here the response polarizes as APCs bind to either positive or negative costimulatory signals 
(Fig. 1.5A). Activation is boosted by CD28 binding during an infection and diminished by CTLA-4 
binding during peripheral tolerance. The high sensitivity of T-cell recognition is achieved by 
extensive membrane protein reorganization at the IS into spatially discrete zones of 
supramolecular activation clusters (SMACs), which resembles a bull’s-eye (Fig. 1.5B). Sustained 
signaling in a mature IS for CD4+ T-cell is mediated by TCRs in small clusters of 5-30 molecules 
moving centripetally toward central SMAC (cSMAC)(Dustin, Chakraborty et al. 2010). 
Costimulatory receptors CD28 and co-receptor CD4 and Cd8 are also found in the cSMAC. 
Cluster size regulates protein sorting at the IS. And larger ectodomains are relegated to the 
peripheral SMAC (pSMAC). Noted is the segregation of integrin receptor, LFA-1, to the pSMAC. 
The adhesive receptor binds to ICAM-1 on APCs to further stabilize the IS by creating a seal. 
CD45, a protein tyrosine phosphatase that has net negative effect on downstream signaling 




Figure 1.5: A. Immunological synapse is the site of critical ligand interactions. T-cells are primed when TCR 
recognize specific peptide-loaded MHC. Then costimulatory signal is given by APC via its binding to either CD28 
or CTLA-4 receptors. The signaling structure is further stabilized by adhesive receptor LFA-1, which binds to 
ICAM-1 on APCs. From (Abbas, Lichtman et al. 2007). B. The high sensitivity of T-cell recognition is made possible 
by the formation of spatially discrete zones within the SMAC. Adapted from (Dustin, Chakraborty et al. 2010). 
Intracellularly, TCR has no cytosolic signaling domains. Its signal is propagated by the CD3 
complex through the phosphorylation of immunoreceptor tyrosine-based activation motifs 
(ITAMs) by lymphocyte-specific protein tyrosine kinases (Lck) for further downstream signaling. 
Positive costimulation induces signaling cascade critical to proliferation and differentiation; and 
understanding the interplay between CD3 and CD28 is the key to improving and modulating ex 
vivo T-cell expansion for adoptive immunotherapy.  
1.6 The Spatial and Functional Interactions in T-cell 
Activation 
Beyond size exclusion, Michael Dustin’s group studied the effect of APC costimulatory 
presentation on T-cell spatial segregation and function. The Dustin group generated an artificial 
APC with either a full-length CD80 (CD80FL) or a cytoplasmic tail deleted mutant (CD80TL), both 
tagged with yellow fluorescent proteins (YFPs). Peptide-loaded MHC-II (specifically the I-Ek 
pMHC complex), ICAM-1 and either one of the CD80 constructs were inserted into Chinese 
hamster ovary (CHO) cells functioning as an artificial APCs for mouse T-cells. To assess 
functional differences, the Dustin group measured proliferation both via [3H] thymidine 
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incorporation and IL-2 secretion. Functionally, the assays revealed that CD80FL induces superior 
proliferation than CD80TL. However CD80TL still performs better than MHC-II alone without 
CD28 engagements (Tseng, Liu et al. 2005).  
The Dustin group decided to examine the spatial distribution within the IS. Without CD80 
engagement, TCR does not migrate to the cSMAC and mixes with LFA-1 at the interface (Fig. 
1.6A). With CD80 engagement, TCRs move into the cSMAC. For CD80FL, CD80/CD28 is 
segregated from TCR-CD3 clusters (Fig. 1.6B); however CD80TL colocalizes with TCR (Fig. 1.6C). 
The study revealed that functional impairments affect spatial organizations.  
 
Figure 1.6: The effect of CD80 on TCR spatial organization. A. The APC presents only MHC-II and LFA-1. CD80 is 
necessary for TCR migration to the cSMAC. Its absence results in loss of spatial segregation as TCR (red) mixes 
with LFA-1 (blue). B. With full-length CD80, one observes segregation of CD80FL from TCR clusters. C. With tail 
deleted CD80, CD80TL colocalizes with TCR. Scale bar = 2µm. From (Tseng, Liu et al. 2005) 
Our group attempted to invert the relationship. We wanted to understand if ex vivo T-cell 
exposure to activating proteins in different spatial arrangements can modulate T-cell 
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activations. Our group recapitulated the spatial cues with activating antibodies printed on glass 
surfaces. To induce functional impairments with TCR-CD3/CD28 colocalization (Fig. 1.6C), 
antibodies activating CD3 and CD28 were mixed together and absorbed onto 2µm-dot stamps; 
then the proteins were printed onto clean glass surfaces. To elicit a strong activation by 
spatially segregating the TCR-CD3 and CD28 proteins (Fig. 1.6B), we coated and stamped 2µm-
dot stamps with anti-CD3 antibody (-CD3) and 1µm-dot stamps with anti-CD28 antibody (-
CD28). And to assess T-cell activation in response to the different patterns, again IL-2 secretion 
was measured.  
We were able to demonstrate that inversely spatial cues affect T-cell activations. And our 
results concur with the CD80 study from the Dustin group. Without CD28 engagement (CD3-
only), IL-2 secretion was very weak. Colocalized (COL) surface exhibited slightly stronger 
secretion. And segregated (SEG) surface demonstrated strongest IL-2 secretion, 2- to 3- fold 
higher than the COL patterns. To better understand the spatial effect of CD3 and CD28 on T-cell 
activation, 2 additional surfaces were examined. One tested if the positive modulation was 
purely due to the separation of CD3 and CD28 by creating a reverse segregated surface (REV-
SEG).  2µm-dot stamps were coated with -CD28 while 1µm-dots were coated with -CD3. A 
marked decrease in IL-2 secretion was observed on REV-SEG patterns. Finally, to test if 
peripheral presentation of CD28 is the key to strong IL-2 secretion, mixture of CD28 and CD3 
coated 1µm-dot stamp (REV-COL). And it gave the strongest response (Fig. 1.7A). We concluded 
that peripheral presentation of CD28 induces robust response, and not the segregation of CD3 




Figure 1.7: A. Mouse T-cells respond robustly to peripheral presentation of CD28. From (Shen, Thomas et al. 
2008). B. Human T-cells respond most potently to colocalized presentation of CD3 and CD28, and also peripheral 
presentation of the proteins. From (Bashour, Tsai et al. 2014).   
More relevant to adoptive T-cell immunotherapy would be human T-cell and its response to 
spatial cues. Thus similar experiments were conducted on naïve peripheral blood human T-cells. 
As with mouse T-cells, CD3 only patterns resulted in minimal IL-2 secretion. However, unlike 
mouse T-cells, human cells did not tolerate CD3/CD28 separation, as seen on SEG and 
peripheral SEG (PSG) patterns.  In terms of IL-2 secretion, SEG and PSG exhibited similar 
response to CD3 only patterns. And like mouse T-cells, peripheral presentation enhanced IL-2 
secretion, as seen on centrally COL (CCO) versus peripheral COL (PCO) patterns (Fig. 1.7B). In 
fact, PCO patterns generated comparable quantity of IL-2 as fully coated surfaces. The results 
have significant implication for pharmaceutical research. Certainly, it may help to explain why 
many drug candidates that appeared promising in mouse preclinical immunological studies 
utterly fail in human clinical trials.  
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Next we sought out a protein or a pathway to explain the observed differences in mouse and 
human T-cells. One protein that interacts with both CD3 and CD28 is Lck. As alluded to 
previously, the effect of activated Lck or phospho-Lck (pLck) on CD3-associated signaling is well 
understood (Fig. 1.8A). PLck phosphorylates ITAMs (pITAMs) on the CD3 complexes. PITAMs 
become a binding site for the SH2 domains on ZAP-70. Its recruitment to pITAM results in 
ZAP70 activation/phosphorylation by pLck. Activated ZAP70 phosphorylates scaffold proteins 
LAT and SLP-76 for the recruitment of PLC, initiating extensive signaling networks (Alegre, 
Frauwirth et al. 2001, Koretzky and Myung 2001). PLck role in CD28 signaling is less understood. 
PLck is one of the two candidates shown to phosphorylate the YMNM motif on CD28. Lck is also 
recruited to PYAP to activate PDK1 (Fig. 1.8B) (Boomer and Green 2010).  
 
Figure 1.8: A. Well established is the role of pLck in TCR/CD3 complex-associated signaling. Lck phosphorylates 
ITAMs on CD3. Then pITAMs act as docking sites for ZAP70 by interacting with the ZAP70 SH2 domains. ZAP70 
initiates a network of signaling proteins with diverse functions. Adapted from (Koretzky and Myung 2001). B. 
Less understood is the role of pLck in CD28-associated signaling. Two signaling pathways have been discovered 
for CD28. One is a PI3K (the p86-p110 heterodimer)-dependent pathway, and another is an adaptor protein 
(Grb2 or GADS)-dependent pathway. Suspect of phosphorylating the YMNM motifs on CD28, Lck is known also 
to activate PDK1. Adapted from (Boomer and Green 2010). 
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Fixed stainings of pLck on patterned surfaces revealed a difference between mouse and human 
T-cells. In mouse T-cells, pLck is distributed throughout the interface regardless of the 
patterned surfaces (Fig. 1.9A). In human T-cell, pLck preferentially localizes to TCR-CD3 with 
minor overlap on CD28 (Fig. 1.9B). In contrast, total Lck is distributed evenly across the 
interface (not shown) (Bashour, Tsai et al. 2014). Many models have been formulated to explain 
cellular regulation of pLck activity. In this case, because pLck must translocate between CD3 and 
CD28 to initiate signaling cascade, a balance must exist between Lck diffusion and pLck 
dephosphorylation (Fig. 1.9C). A former lab member, Keenan Bashour, studied Lck diffusion via 
fluorescence recovery after photobleaching (FRAP). He found diffusion to be faster in mouse T-
cells, at about 0.37 ± 0.017 μm2/s. PLck diffusion in human T-cells clocked in at 0.04 ± 0.02 
μm2/s, 8-folds slower.  
 





Figure 1.9: A. Stainings in mouse T-cells revealed pLck to be localized throughout the interface, regardless of the 
patterned surfaces. From (Bashour, Tsai et al. 2014). B. Human T-cell stainings of pLck revealed a preference for 
CD3, with lesser overlap on CD28. From (Bashour, Tsai et al. 2014). C. Translocation of Lck between TCR-CD3 
complex and CD28 to initiate signaling cascade will be a function of Lck diffusion and pLck dephosphorylation.  
Please note: pLck staining was performed with pY394 antibody, which is unable to distinguish between pLck and 
pFyn. Thus, it’s referred to as pSFK. 
While the rate of Lck diffusion could partial account for the differential responses between the 
species, it still does not address the role of phosphatase activity on Lck kinase activity. Thus, this 
dissertation focuses on creating reporters of Lck kinase activity. 
1.7 Significance 
Adoptive Immunotherapy is a promising treatment to combat certain types of cancers. And the 
plasticity of CD4+ T helper cells makes it an attractive target for cellular immunotherapy. 
Critical to the modulation of T helper cell activation and differentiation is the costimulatory 
signal. And a deeper understanding of the pathways governing the process is crucial to better 
engineer or direct the immune responses against cancerous cells.  
Lck arose as a master initiator of intracellular signaling cascades. And the acute differences in 
mouse and human T-cell activations hopefully will help to elucidate the means of cellular 






2. Designing a Reporter of Lck 
Kinase Activity 
2.1 Introduction 
Lck is a member of the Src family kinases (SFK). The family is highly conserved and present in 
essentially all metazoan cells, in response to external stimuli. Another SFK relevant to immune 
response is Fyn, which is difficult to differentiate from Lck, and will be discussed in detail later.   
As an essential kinase in T-cell activation, Lck activity is highly regulated by conformational 
changes. Specifically, the kinase activity is controlled via phosphorylation and 
dephosphorylation of two regulatory tyrosine residues. To understand this conformational 
regulation, it’s important to understand the structure of Lck. In general, SFKs share a number of 
conserved domains. At the N-terminus is a SH4 domain. Lck SH4 domain is both myristoylated 
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and palmitoylated for membrane-targeting. Next are the SH3, SH2, and kinase (SH1) domains. 
The hallmarks of SFK are an autoinhibitory tyrosine at the C-terminus just downstream of the 
SH1 domain and an activating tyrosine in the kinase activation loop in the SH1 domain.  
The autoinhibitory tyrosine (Y527 in Src or Y505 in Lck) is phosphorylated by Csk or its homolog 
Chk and dephosphorylated byCD45 (Rossy, Williamson et al. 2012). Phosphorylated Y527 binds 
with Arg175 in the SH2 domain (Fig. 2.1  ). And the steric and electrostatic factors result in an 
intramolecular interaction between SH2, SH3, and the linker segment to the kinase domain (Fig. 
2.1 ). These two intramolecular bindings pack against the back of the catalytic domain. 
Without sterically occluding the catalytic cleft, the interactions result in the active site is locked 
into an inactive conformation (Fig. 2.1 ). The activating tyrosine (Y416 in c-Src or Y394 in Lck) 
is buried into the cleft, unable to be phosphorylated (Boggon and Eck 2004), which necessary 
for its kinase activity. 
 
Figure 2.1: Autoinhibited kinase is characterized by the activating Y416 being buried in the active site cleft . 
This is achieved by two intramolecular interactions: pY527 binding with R175  and SH2-SH3-kinase linker 
packing against the back of the catalytic domain . In the activated form, pY416 pins the active site open .  
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Adapted from (Boggon and Eck 2004). 
In contrast, pY416 pins the activation loop in an active conformation (Fig. 2.1 ). Y416 
phosphorylation is achieved in a process known as trans-autophosphorylation. And its 
dephosphorylation is carried out by CD45. (Rossy, Williamson et al. 2012). Consensus within 
literature is that CD45 has a predominately negative effect on Lck activity. Kinetically, high level 
of CD45 is required to dephosphorylate Y394 and suppress Lck activity. Meanwhile low level of 
CD45 favors Y505 dephosphorylation, which enhances Lck activity. Under basal conditions, 
CD45 concentration is very high thus restraining Lck activity. However, during IS formation, 
CD45 is segregated to dSMAC. It’s inferred to favor Y505 dephosphorylation and to enhance Lck 
kinase activity. 
Stirnweiss and colleagues constructed a Förster resonance energy transfer (FRET) biosensor to 
study Lck conformational change (Stirnweiss, Hartig et al. 2013). The group studied Lck in 
JCAM1.6, a Jurkat mutant with no Lck activity. And Jurkat is a leukemic T-cell line. The reporter 
had a fully functional Lck. Its insertion into JCAM1.6 restores cellular signaling. To report Lck 
conformation, Stirnweiss inserted a donor (eCFP) between the membrane targeting domain 






Figure 2.2:  A. Diagram of the constructs. CLckY-1 is a fully functional Lck. Y505F, having removed the autoinhibitory tyrosine, 
is the ‘open’ form. Y394F cannot be phosphorylated, is the ‘closed’ form. Finally ECYFP is a positive control for FRET 
response. B. Spectral emission in JCam1.6 for the four constructs. Adapted from (Stirnweiss, Hartig et al. 2013).  
When the protein is in the autoinhibited and closed state, FRET intensity will increase as SH2-
SH3-tail domains pack together, against the back of the catalytic domain. When Lck is activated, 
the SH2-SH3 clamp releases and Y505 is dephosphorylated, thus separating the donor and the 
acceptor fluorescent proteins and quenching the FRET response. To explore the dynamic range 
of the reporter, the authors also produced two mutants. One removed the autoinhibitory 
tyrosine, thus always in the ‘open’ conformation (Fig. 2.2A CLckY-1-Y505F). Another removed 
the activating tyrosine, thus always in the ‘closed’ conformation (Fig. 2.2A CLckY-1-Y394F). As 
expected, the ‘closed’ or inactive form (CLckY-1-Y394F) had the strongest FRET response, while 
‘open’ or active form (CLckY-1-Y505F) had the weakest (Fig. 2.2B). In unstimulated JCAM1.6 
cells, CLckY-1 reported that 16% of the constructs exhibited an ‘open’ conformation. Upon -
CD3 stimulation, the biosensor reported a 20% increase at the plasma membrane (Stirnweiss, 
Hartig et al. 2013). However, not much is revealed about Lck kinase activity. 
Table 2.1: Four functional forms of Lck in T-cells. JCAM1.6 is a mutant from of Jurkat cells. From (Nika, Soldani et 
al. 2010). 
 
To complicate the story of Lck conformational regulation, there are two additional protein 
states. The canonical forms are closed, inactive Lck (pY505) and active Lck (pY394). When both 
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tyrosines are dephosphorylated it’s referred to as ‘primed’. And when both tyrosines are 
phosphorylated (DPho), the protein is enzymatically active (Nika, Soldani et al. 2010). In naïve 
human T-cells ~38% of total Lck was constitutively activated (Table 2.1).  
Other studies reported that Lck activation was independent of TCR engagement. It’s the 
dynamic regulation of Lck to the IS that regulates Lck kinase activity (Nika, Soldani et al. 2010).  
Thus, a real-time spatiotemporal reporter of Lck kinase activity is needed to study the 
modulatory effect of CD28 on T-cell activation.  
2.2 Materials and Method 
2.2.1 ZIP Plasmid Preparation. 
ZIP reporter from the Vale group was purchased from Addgene (Cambridge, MA), a nonprofit 
plasmid repository. The sequence was inserted into a pHR vector with ampicillin resistance. And 
each domain was flanked with unique restriction enzymes for ease of manipulation. CD3 and 
eGFP was removed by a double digest of AscI and MscI (New England Biolab, R0534 and 
R0558). Because MscI is dcm methylation sensitive, ZIP was cloned in a bacteria strain that is 
deficient in the methylase. Thus ZIP was expanded in INV110 (Invitrogen, C7171-03) before 
enzymatic digestions. 




A custom plasmid was synthesized by Invitrogen via GeneArt: in a pMK-RQ backbone with 
Kanamycin resistance, plus AscI and MscI recognition sites to flank the 1030bp sequence of 
interest. Like ZIP reporter, the construct was expanded in INV110 and double digested by 
restriction enzymes AscI and MscI.  
2.2.3 Building Lck Kinase Activity FRET reporter (LckR_FRET) 
To construct the Lck kinase activity FRET reporter, the two fragments from ZIP and GeneArt 
custom plasmid were ligated together. The ligation was completed using a T4 DNA Ligase (New 
England Biolab, M0202) at a 1:9 molar ratio of ZIP: custom plasmid fragments. To prevent self-
ligation of the ZIP fragments, they were treated with Antarctic Phosphatase (New England 
Biolab, M0289) to dephosphorylate the 5’-ends. The original plan was to introduce the religated 
plasmid into cells via electroporation. The pHR-LckR_FRET plasmid was about 11.45kb, too large 
for a viable and efficient cellular transfection. To trim the vector, the retroviral machinery was 
removed using a HindIII digestion of full length ZIP plasmid (Fig. 2.3). And the largest two 
fragments contained both the ZIP reporter and the bacteria replication machinery, which were 
religated together. The final LckR_FRET reporter was trimmed to 6.3kb. The plasmid was 
sequenced to validate its DNA fidelity using 10 primers: CTGCTTCTCGCTTCTGTTC, 
AGTACAGCCACCAAGGACAC, CGTCCTTGAAGAAGATGGTC, CATCAAGGCCAACTTCAAGA, 
ATGATGGCCATGTTATCCTC, AGTTCATGTACGGCTCCAAG, TAGGTGGTCTTGACCTCAGC, 




Figure 2.3: The HindII digestion of pHR-ZIP. The enzyme digested the plasmid into eight fragments. The largest 
fragment 7758-11197 contained the ZIP reporter. And the second largest fragment 238-3473 had the bacterial 
origin of replication and ampicillin resistance for selection. The two pieces were recovered and religated 
together.  
2.2.4 Glass Substrate Preparation. 
Glass coverslips were cleaned in hot detergent (Linbro 7X, diluted with deionized water), rinsed 
with MilliQ-grade water, and then baked at 450°C for 6 h. 
NIH 3T3 cells naturally adhere to glass thus does not require the coverslides to be treated with 
adhesive proteins. Jurkat E6.1 cells are suspension cells, and will only adhere and spread upon 
its activation. Thus glass coverslips were incubated with 5μg/mL : 5μg/mL : 2μg/mL mixture of 
-CD3 (clone OKT3 from M Sheetz’ laboratory, Columbia University) : -CD28 (clone 9.3 from 
BioXCell, BE0248) : human ICAM-1 (R&D Systems CD54 Fc Chimera Protein) for 2h.  
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2.2.5 NIH 3T3 and Jurkat Cell Culturing  
Mouse NIH3T3 embryonic fibroblast (gift of Emily Moore, Christopher Jacobs’ laboratory at 
Columbia University) was maintained in DMEM (Sigma, D6429) with 10% FBS (Hyclone 
SH30071.03) and 50 U/mL Penicillin & Streptomycin. Jurkat E6.1, human leukemic T-
lymphoblast (American Type Culture Collection, TIB-152) was maintained in RPMI 1640 (Gibco 
32404), 10% FBS, 10mM HEPES, 50 U/mL Penicillin & Streptomycin, 2mM L-glutamine, and 
50µM -Mercaptoethanol. For live cell imaging, to minimize autofluorescent interference, 
media without phenol red were used (Gibco 11835). And to maintain the condition at 37°C, 
LiveCellTM heating chamber was mounted onto the microscope, connect to a 5% CO2 air tank.  
2.2.6 Nucleic Acid Transfection 
Transfection was performed in the Neon Transfection System (Invitrogen), using the 
recommended settings. Post transfection, cells recovered in the appropriate prewarmed media. 
For DNA-transfection, NIH3T3 cells were left to recover overnight.  
Despite trimming the vector to 6.3Kb, the Jurkat could not tolerate the large vector. Using 
CellScript (Madison, WI), mRNA transcription of LckR_FRET was performed in vitro. Post mRNA-
transfection, cells were ready after a 5 h recovery. 




Jurkat cells expressing LckR_FRET mRNA were incubated on glass precoated with activating 
antibody for 15 min, fixed, and imaged. For PP2 studies, Jurkat cells were preincubated with the 
antagonist (Calbiochem 529573) for 30min at 10µM. 
Cells were fixed with 1:1 mixture of 4% paraformaldehyde: PHEM buffer for 15 minutes. Then 
washed with PBS before imaging. 
2.2.8 Data Acquisition  
All images were collected via an Olympus IX81 inverted microscope equipped with 20x, 60x, 
and 100x objectives. Images were collected using Andor iXon3 EM-CCD. LckR_FRET was imaged 
using TIRF microscopy (excitation 480nm, 100x/1.45 oil immersion objective): donor emitter 
filter S535/40M and acceptor emitter filter S610/40M.  
The MetaMorph software for Olympus was used to acquire the images. Image processing was 
done on both MetaMorph and ImageJ. Functions used include, but are not limited to: 
overlaying multiple channels, background subtraction, and median filtration. Where 
appropriate, certain functions of image analysis were performed in Matlab. 
2.2.9 Data Analysis for LckR_FRET 
The analysis was adapted from Na and colleagues (Na and Wang 2008). Subtraction of 
background signal was performed with MetaMorph. Using Matlab, alignment was performed 
pixel-by-pixel maximizing the normalized cross-correlation coefficient of YPET and mCherry. 
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With proper background subtraction, no mask was needed. FRET ratio was defined as 
mCherry/YPET intensity on TIRF. FRET ratio was measured averaging 1-4 regions of interest 
(ROIs) per cell.  The FRET ratio was then analyzed using standard ANOVA and performed with 
the OriginPro 8 software. 





%%  Pre-treating the data using MetaMorph%% 
% select an area as the background using trace region icon 
% BACKGROUND SUBTRACTION 
% Go to 'Process' menu  
% --> Background and Shading Correction...  
% --> select source image  
%     select full stack (subtract background from each image of the 
stack) 
% --> Operation: -> Statistical Correction 
% --> Parameters: -> Region Statistics -> Average -> Region number: 1 
  
Sample = '08.tif'; 




num_image = max(size(imfinfo(Sample))); 
[YFPcr rect] = imcrop(imadjust(imread(Sample,1))); % YFPcr: adjusted 
image intensity (like in imageJ) 
title('Crop the YFP/Donor image'); 
[isize jsize] = size(YFPcr); 
  
% Initialize variables 
offsets = zeros(num_image,3); 




YFPcrop = imcrop(imread(Sample,1), rect); % YFPcrop: intensity 
unadjusted image 
  
mFP = imadjust(imread(Sample,2)); % Read in the mCherry image as the 
base 
A = normxcorr2(YFPcrop,mFP); % Template is YFP cropped image, base is 
mCherry 
  
[max_A, imax] = max(abs(A(:))); 
[ipeak, jpeak] = ind2sub(size(A),imax(1)); 
corr_offset1 = [ (ipeak-size(YFPcrop,1)) (jpeak-size(YFPcrop,2)) ]; % 
How the template image needs to translate [i distance, j distance] 
offsets(1,1:2) = corr_offset1; 
offsets(1,3) = max_A; 
rect_new = [corr_offset1(2)+.51, corr_offset1(1)+.51,rect(3),rect(4)]; 
mFPcrop = imcrop(imread(Sample,2), rect_new); % Crop the mCherry image 
unadjusted 
     
% Calculate FRET ratio, mCherry/YFP on a pixel-by-pixel basis 
FRETratio = (double(mFPcrop) ./ double(YFPcrop)); 
%unadjusted/unadjusted 
FRETratio(isnan(FRETratio)) = 0; 
FRETratio(isinf(FRETratio)) = 0; 
  
EPI_YPET = imcrop(imread(Raw,5),rect); 
EPI_mCherry = imcrop(imread(Raw,6),rect); 
  
EPIratio = (double(EPI_YPET ) ./ double(EPI_mCherry)); 
%unadjusted/unadjusted 
EPIratio(isnan(EPIratio)) = 0; 






%  Define ROI of the cell body 
figure   
bg2 = imcrop(imadjust(imread(Sample,1)),rect); 
im2 = imcrop(imadjust(imread(Sample,3)),rect); 








[ROI1 xi1body yi1body]=roipoly; 
  
title('Select cells') 
[ROI2 xi2body yi2body]=roipoly; 
  
title('Select cells') 
[ROI3 xi3body yi3body]=roipoly; 
  
FRET1 = FRETratio.*ROI1; 
EPI1 = EPIratio.*ROI1; 
FRETmean1 = mean2(FRET1(ROI1==1)); 
EPImean1 = mean2(EPI1(ROI1==1)); 
  
FRET2 = FRETratio.*ROI2; 
EPI2 = EPIratio.*ROI2; 
FRETmean2 = mean2(FRET2(ROI2==1)); 
EPImean2 = mean2(EPI2(ROI2==1)); 
  
FRET3 = FRETratio.*ROI3; 
EPI3 = EPIratio.*ROI3; 
FRETmean3 = mean2(FRET3(ROI3==1)); 
EPImean3 = mean2(EPI3(ROI3==1)); 
  
FRETmean = (FRETmean1+FRETmean2+FRETmean3)/3; 






2.3.1 Designing the Lck Activity Reporter  
To develop a FRET-based indicator of Lck kinase activity, existing SFK biosensors were 
examined. Wang and colleagues constructed a reporter for Src, the prototype SFK (Wang, 
Botvinick et al. 2005). The reporter had six main domains. First is the membrane-targeting 
domain from Lyn. Next is the FRET donor, a cyan fluorescent protein (eCFP). Then is a SH2 
domain to bind to the substrate.  A flexible linker connects the SH2 domain to the substrate. 
Finally at the C-terminus is the FRET acceptor, a yellow fluorescent protein (eYFP).  The 
substrate is what informs the Src kinase activity. WMEDYDYVHLOG is derived from p130cas; it 
is the peptide that Src phosphorylates in vivo. Upon double tyrosine phosphorylation, SH2-
domain of the reporter binds to the substrate to change the FRET response (Fig. 2.4A). 
 
Figure 2.4: A. Schematic of the Src FRET reporter: membrane-targeting domain (MGCIKSKRKDNLNDDE), donor 
(eCFP), SH2 domain, flexible linker, substrate, and acceptor (eYFP). B. FRET response upon Src activation. 
Adapted from (Wang, Botvinick et al. 2005).  
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In a traditional FRET reporter, FRET intensity increases with enzyme activity. In the case of Src, 
it is the opposite. Without Src the donor and acceptor couple for a positive FRET response. 
Upon Src activation, substrate-SH2 interaction separates the two fluorescent proteins for a 
negative FRET response (Fig. 2.4B) 
For Lck kinase activity, a good substrate is ITAM on CD3. ITAM sequences from both human 
and mouse CD3 (Table 2.2 and Table 2.3) were assessed to find a consensus between the two 
species.  
Table 2.2: Consensus sequence for mouse CD3 (Consensus CDS). 
 
Table 2.3: Consensus sequence for human CD3 (Consensus CDS) 
 
Mouse CD3 - 495nt
1_ATGAAGTGGA AAGTGTCTGT TCTCGCCTGC ATCCTCCACG TGCGGTTCCC
51_AGGAGCAGAG GCACAGAGCT TTGGTCTGCT GGATCCCAAA CTCTGCTACT
101_TGCTAGATGG AATCCTCTTC ATCTACGGAG TCATCATCAC AGCCCTGTAC
151_CTGAGAGCAA AATTCAGCAG GAGTGCAGAG ACTGCTGCCA ACCTGCAGGA
201_CCCCAACCAG CTCTACAATG AGCTCAATCT AGGGCGAAGA GAGGAATATG
251_ACGTCTTGGA GAAGAAGCGG GCTCGGGATC CAGAGATGGG AGGCAAACAG
301_CAGAGGAGGA GGAACCCCCA GGAAGGCGTA TACAATGCAC TGCAGAAAGA
351_CAAGATGGCA GAAGCCTACA GTGAGATCGG CACAAAAGGC GAGAGGCGGA
401_GAGGCAAGGG GCACGATGGC CTTTACCAGG GTCTCAGCAC TGCCACCAAG
451_GACACCTATG ATGCCCTGCA TATGCAGACC CTGGCCCCTC GCTAA
Human CD3 - 492nt
1_ATGAAGTGGA AGGCGCTTTT CACCGCGGCC ATCCTGCAGG CACAGTTGCC
51_GATTACAGAG GCACAGAGCT TTGGCCTGCT GGATCCCAAA CTCTGCTACC
101_TGCTGGATGG AATCCTCTTC ATCTATGGTG TCATTCTCAC TGCCTTGTTC
151_CTGAGAGTGA AGTTCAGCAG GAGCGCAGAC GCCCCCGCGT ACCAGCAGGG
201_CCAGAACCAG CTCTATAACG AGCTCAATCT AGGACGAAGA GAGGAGTACG
251_ATGTTTTGGA CAAGAGACGT GGCCGGGACC CTGAGATGGG GGGAAAGCCG
301_AGAAGGAAGA ACCCTCAGGA AGGCCTGTAC AATGAACTGC AGAAAGATAA
351_GATGGCGGAG GCCTACAGTG AGATTGGGAT GAAAGGCGAG CGCCGGAGGG
401_GCAAGGGGCA CGATGGCCTT TACCAGGGTC TCAGTACAGC CACCAAGGAC




  1 MKWKVSVLAC ILHVRFPGAE AQSFGLLDPK LCYLLDGILF IYGVIITALY 
 51 LRAKFSRSAE TAANLQDPNQ LYNELNLGRR EEYDVLEKKR ARDPEMGGKQ 
101 QRRRNPQEGV YNALQKDKMA EAYSEIGTKG ERRRGKGHDG LYQGLSTATK 
151 DTYDALHMQT LAPR 
Human CD3 
  1 MKWKALFTAA ILQAQLPITE AQSFGLLDPK LCYLLDGILF IYGVILTALF 
 51 LRVKFSRSAD APAYQQGQNQ LYNELNLGRR EEYDVLDKRR GRDPEMGGKP 
101 QRRKNPQEGL YNELQKDKMA EAYSEIGMKG ERRRGKGHDG LYQGLSTATK 
150 DTYDALHMQA LPPR 
CD3 is well-conserved. Almost identical in length, the human CD3 has a deletion of a 
glutamine at Q101. Structurally there are 3 major domains. First, the signaling domain, 
underline above, targets CD3 for the cytoplasmic membrane. Next is the transmembrane 
domain, highlighted in blue. Finally, CD3 has 3 ITAMs, in green. Focusing on the ITAMs, the 
third one is the best candidate for the substrate domain of the reporter because it’s identical 
between the two species (Fig. 2.5).  
 
Figure 2.5: ITAMs in CD3. The motifs are well conserved between the species. Differences are highlighted in 
white. ITAM3 is identical between human and mouse. 
 
               ITAM 1                  ITAM 2                   ITAM 3      
Mouse NQ LYNELNLGRR EEYDVLEKK EGV YNALQKDKMA EAYSEIGTK DG LYQGLSTATK DTYDALHMQ 
Human NQ LYNELNLGRR EEYDVLDKR EGL YNELQKDKMA EAYSEIGMK DG LYQGLSTATK DTYDALHMQ 
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In vivo, SH2 domain of ZAP70 binds to the phosphorylated ITAMs, thus a natural candidate for 
the reporter. And the species does not matter. The reporter should also migrate with the target 
protein, thus Lck membrane target domain (MGCGCSSNPE), also known as Lck10, should be 
added to the biosensor.  
2.3.2 Building the Lck Activity Reporter  
Instead of building the reporter from scratch, fragments were salvaged from other FRET 
reporters. The Vale group made a FRET biosensor to report on CD3 zeta chain ITAM 
phosphorylation, or ZIPWT (Yudushkin and Vale 2010). The construct had a full length CD3, 
donor fluorescent protein (eGFP), linker (GPGSASGEGLPGSAGPG), acceptor fluorescent protein 
(mCherry), and SH2 from human ZAP70 (residues 1-259) (Fig. 2.6A, Table 2.4). Instead of 
measuring the intensities of donor and acceptor fluorescent proteins, the Vale group utilized 
fluorescent-lifetime imaging microscopy (FLIM). FRET response was measured via eGFP lifetime; 
upon energy transfer, the length of the eGFP lifetime was shortened. Looking at the dynamic 
range of the ZIP reporter, two other mutants were explored. One construct removed all the 
tyrosines in ITAM (ZIPYF), another removed the arginines in SH2, which bind to the 




Figure 2.6: A. Diagram of the ZIP reporter. It contains full-length CD3, eGFP, linker, mCherry, and human SH2. B. 
Jurkat transfected with ZIPWT, ZIPYF, and ZIPR37K/R180K; the cells adhered onto glass precoated with -CD3 antibody 
for 10min before being fixed and measured using TCSPC-FLIM. From (Yudushkin and Vale 2010). 
As expected, ZIPWT exhibited shortening of eGFP lifetime upon -CD3 activation. ZIPYF and 
ZIPR37K/R180K, unable to form an intramolecular interaction between the SH2 domain and the 
ITAMs had extended eGFP lifetime (Fig. 2.6B).  
Table 2.4: Sequence for ZIPWT. It contains five discrete domains: CD3, eGFP, linker, mCherry, and SH2.  
 
-121              GGCGC GCCagtcctc 
 -61 cgacagactg agtcgcccgg gggggatctg gagctctcga gaattctcac gcgtgccacc 
   1 ATGaagtgga aagtgtctgt tctcgcctgc atcctccacg tgcggttccc aggagcagag    
  61 gcacagagct ttggtctgct ggatcccaaa ctctgctact tgctagatgg aatcctcttc      
 121  atctacggag tcatcatcac agccctgtac ctgagagcaa aattcagcag gagtgcagag   
 181  actgctgcca acctgcagga ccccaaccag ctctacaatg agctcaatct agggcgaaga   
 241  gaggaatatg acgtcttgga gaagaagcgg gctcgggatc cagagatggg aggcaaacag  
 301  cagaggagga ggaaccccca ggaaggcgta tacaatgcac tgcagaaaga caagatggca  
 361  gaagcctaca gtgagatcgg cacaaaaggc gagaggcgga gaggcaaggg gcacgatggc  
 421  ctttaccagg gtctcagcac tgccaccaag gacacctatg atgccctgCA TATGcagacc   
 481  ctggcccctc gcccaccggt cgccaccATG gtgagcaagg gcgaggagct gttcaccggg  
 541 gtggtgccca tcCTGGTCGA GCTGGACGGC GACGTAaacg gccacaagtt cagcgtgtcc  
 601  ggcgagggcg agggcgatgc cacctacggc aagctgaccc tgaagttcat ctgcaccacc  
 661  ggcaagctgc ccgtgccctg gcccaccctc gtgaccaccc tgacctacgg cgtgcagtgc  
 721  ttcagccgct accccgacca catgaagcag cacgacttct tcaagtccgc catgcccgaa  
 781  ggctacgtcc aggagcgcac catcttcttc aaggacgacg gcaactacaa gacccgcgcc  
 847  gaggtgaagt tcgagggcga caccctggtg aaccgcatcg agctgaaggg catcgacttc  
 901  aaggaggacg gcaacatcct ggggcacaag ctggagtaca actacaacag ccacaacgtc  
 961  tatatcatgg ccgacaagca gaagaacggc atcaaggtga acttcaagat ccgccacaac 
1021  atcgaggacg gcagcgtgca gctcgccgac cactaccagc agaacacccc catcggcgac 
1081  ggccccgtgc tgctgcccga caaccactac ctgagcaccc agtccgccct gagcaaagac  
1141  cccaacgaga agcgcgatca CATGGTCCTG CTGGAGTTCG TGaccgccgc cgggatcact 




The linker, mCherry, and SH2 from Vale’s construct were salvaged. Modifications were made at 
the N-terminus to ensure that the probe would diffuse with the Lck proteins. Thus the full-
length CD3 domain was replaced with the Lck membrane targeting domain (Lck10), and a 
substrate peptide (ITAM3) (Table 2.5). Instead of FLIM, which captures eGFP lifetime, FRET 
1141  cccaacgaga agcgcgatca CATGGTCCTG CTGGAGTTCG TGaccgccgc cgggatcact 
1201  ctcggcatgg acgagctgta caagggacca ggatcggcgt ctggggaagg actgccagga 
1261 tcagccggac caggaatggt gagcaagggc gaggaggata acaTGGCCAt catcaaggag 
1321 ttcatgcgct tcaaggtgca catggagggc tccgtgaacg gccacgagtt cgagatcgag 
1381 ggcgagggcg agggccgccc ctacgagggc acccagaccg ccaagctgaa ggtgaccaag 
1441 ggtggccccc tgcccttcgc ctgggacatc ctgtcccctc agttcatgta cggctccaag 
1501 gcctacgtga agcaccccgc cgacatcccc gactacttga agctgtcctt ccccgagggc 
1561 ttcaagtggg agcgcgtgat gaacttcgag gacggcggcg tggtgaccgt gacccaggac 
1621 tcctccctgc aggacggcga gttcatctac aaggtgaagc tgcgcggcac caacttcccc 
1681 tccgacggcc ccgtaatgca gaagaagacc atgggctggg aggcctcctc cgagcggatg 
1741 taccccgagg acggcgccct gaagggcgag atcaagcaga ggctgaagct gaaggacggc 
1801 ggccactacg acgctgaggt caagaccacc tacaaggcca agaagcccgt gcagctgccc 
1861 ggcgcctaca acgtcaacat caagttggac atcacctccc acaacgagga ctacaccatc 
1921 gtggaacagt acgaacgcgc cgagggccgc cactccaccg gcggcatgga cgagctgtac 
1981 aaGCGATCGC accggtatac aagtttgtac aaaaaagcag gctccgcggc cgcccccttc 
2041 accatgccag accccgcggc gcacctgccc ttcttctacg gcagcatctc gcgtgccgag 
2101 gccgaggagc acctgaagct ggcgggcatg gcggacgggc tcttcctgct gcgccagtgc 
2161 ctgcgctcgc tgggcggcta tgtgctgtcg ctcgtgcacg atgtgcgctt ccaccacttt 
2221 cccatcgagc gccagctcaa cggcacctac gccattgccg gcggcaaagc gcactgtgga 
2281 ccggcagagc tctgcgagtt ctactcgcgc gaccccgacg ggctgccctg caacctgcgc 
2341 aagccgtgca accggccgtc gggcctcgag ccgcagccgg gggtcttcga ctgcctgcga 
2401 gacgccatgg tgcgtgacta cgtgcgccag acgtggaagc tggagggcga ggccctggag 
2461 caggccatca tcagccaggc cccgcaggtg gagaagctca ttgctacgac ggcccacgag 
2521  cggatgccct ggtaccacag cagcctgacg cgtgaggagg ccgagcgcaa actttactct 
2581 ggggcgcaga ccgacggcaa gttcctgctg aggccgcgga aggagcaggg cacatacgcc 
2641 ctgtccctca tctatgggaa gacggtgtac cactacctca tcagccaaga caaggcgggc 
2701 aagtactgca ttcccgaggg caccaagttt gacacgctct ggcagctggt ggagtatctg 
2761 aagctgaagg cggacgggct catctactgc ctgaaggagg cctgccccaa cagcagtgcc 




response was quantified using the intensities of acceptor versus donor fluorescent proteins. 
YPET was selected as the donor because with a 450nm excitation laser, the fluorescent protein 
would more strongly excited, thus more electrons would be available for nonradiative energy 
transfer. YPET was a better candidate, since it’s more blue-shifted (Fig. 2.7) and has greater 
brightness (product of extinction coefficient and quantum yield) than eGFP (Shaner, Steinbach 
et al. 2005). Finally, looking at the spectra overlap between donor and acceptor proteins, YPET-
mCherry overlap was not much less than eGFP-mCherry overlap (Fig. 2.6). So YPET replaced 
eGFP.  
 
Figure 2.7: Spectra for YPET, eGFP and mCherry. YPET has a 30nm blue shift in excitation when compared to 
eGFP. And because mCherry has a wide excitation spectrum, minimal loss experienced in overlap with YPET. 
Black vertical bar denotes the excitation laser wavelength. 
Table 2.5: Sequence for Lck FRET reporter. It contains three domains different from ZIP: Lck10, ITAM3, and YPET 
241             G GCGCGCCagt cctccgacaa  
 301 TAATACGACT CACTATAGGG agacaagctt cgaattATGg gctgtggctg cagctcaaac  
 361 cctgaaccag atccgggaca gATGaaaggc gagcgccgga ggggcaaggg gcacgatggc  
 421 ctttaccagg gtctcagtac agccaccaag gacacctacg acgcccttCA TATGcaggcc 
 481 ctgccccctc gcccaccggt cgccaccATG gtgagcaaag gcgaagagct gttcaccggc 
 541 gtggtgccca tcctggtgga gctggacggc gacgtgaacg gccacaagtt cagcgtgagc  
 601 ggcgagggcg agggcgacgc cacctacggc aagctgaccc tgaagctgct gtgcaccacc 
 661 ggcaagctgc ccgtgccctg gcccaccctg gtgaccaccc tgggctacgg cgtgcagtgc 
 721 ttcgcccggt accccgacca catgaagcag cacgacttct tcaagagcgc catgcccgag  
 781 ggctacgtgc aggagcggac catcttcttc aaggacgacg gcaactacaa gacccgggcc  
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 847 gaggtgaagt tcgagggcga caccctggtg aaccggatcg agctgaaggg catcgacttc  
 901 aaggaggacg gcaacatcct gggccacaag ctggagtaca actacaacag ccacaacgtg  
 961 tacatcaccg ccgacaagca gaagaacggc atcaaggcca acttcaagat ccggcacaac  
1021 atcgaggacg gcggcgtgCA GCTGgccgac cactaccagc agaacacccc catcggcgac 
1081 ggccccgtgc tgctgcccga caaccactac ctgagctacc agagcgccct gttcaaggac  
1141  cccaacgaga agcgggacca catggtgctg ctggagttcc tgaccgccgc cggcatcacc  
1201 gagggcatga acgagctcta taagggacca ggatcggcgt ctggggaagg actgccagga 
2.3.3 Lck Activity FRET Reporter Transfection into Cells 
Before sequencing, subclones were transfected into mouse embryonic fibroblasts, a cell type 
very easy to transfect to check for proper ligation without out-of-frame mutations (Fig. 2.8).  
 
Figure 2.8: Plasmid transfection of LckR_FRET into NIH 3T3 cells to check for out-of-frame mutations. Scale bar = 
10µm.  
Then the final plasmid for LckR-FRET was sequenced.  
   1 MGCGCSSNPE PDPGQMKGER RRGKGHDGLY QGLSTATKDT YDALHMQALP PRPPVATMVS 
  61 KGEELFTGVV PILVELDGDV NGHKFSVSGE GEGDATYGKL TLKLLCTTGK LPVPWPTLVT 
 121  TLGYGVQCFA RYPDHMKQHD FFKSAMPEGY VQERTIFFKD DGNYKTRAEV KFEGDTLVNR 
 181  IELKGIDFKE DGNILGHKLE YNYNSHNVYI TADKQKNGIK ANFKIRHNIE DGGVQLADHY 
 241  QQNTPIGDGP VLLPDNHYLS YQSALFKDPN EKRDHMVLLE FLTAAGITEG MNELYKGPGS 
 301 ASGEGLPGSA GPGMVSKGEE DNMAIIKEFM RFKVHMEGSV NGHEFEIEGE GEGRPYEGTQ   
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 361 TAKLKVTKGG PLPFAWDILS PQFMYGSKAY VKHPADIPDY LKLSFPEGFK WERVMNFEDG  
 421 GVVTVTQDSS LQDGEFIYKV KLRGTNFPSD GPVMQKKTMG WEASSERMYP EDGALKGEIK 
 481 QRLKLKDGGH YDAEVKTTYK AKKPVQLPGA YNVNIKLDIT SHNEDYTIVE QYERAEGRHS 
 541 TGGMDELYKR SHRYTSLYKK AGSAAAPFTM PDPAAHLPFF YGSISRAEAE EHLKLAGMAD  
 601 GLFLLRQCLR SLGGYVLSLV HDVRFHHFPI ERQLNGTYAI AGGKAHCGPA ELCEFYSRDP 
 661 DGLPCNLRKP CNRPSGLEPQ PGVFDCLRDA MVRDYVRQTW KLEGEALEQA IISQAPQVEK 
 721 LIATTAHERM PWYHSSLTRE EAERKLYSGA QTDGKFLLRP RKEQGTYALS LIYGKTVYHY 
 781 LISQDKAGKY CIPEGTKFDT LWQLVEYLKL KADGLIYCLK EACPNSSAPG HHHHHH  
Two approaches were available to investigate the dynamic range of the LckR_FRET reporter. 
Wang and colleagues studied the Src reporter using the purified protein. Emission ratios of 
donor/acceptor were measured via cuvettes after the addition of ATPs.  Unfortunately this 
method was abandoned because Lck10 resulted in the LckR_FRET reporters being translocated 
to the bacterial cellular membrane, thus very difficult to isolate.  
Another approach was the method utilized by the Vale group. Briefly, Vale transfected the ZIP 
reporter into Jurkat cells. The cells were either preincubated with PP2, a SFK antagonist, or not. 
Then the cells were permit to adhere onto activating glass coverslips before being fixed and 
imaged via FLIM.  
The Jurkat cell line is difficult to transfect, as immune cells are naturally adverse to take up 
foreign genetic materials, because it mimics a viral infection. The Vale group opted to use 
lentiviral transductions. However, the methodology is incompatible with naïve primary T-cells, 
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the focus of our group’s work on micropatterned surfaces. Thus electrophoresis was used to 
transfect cells with in vitro transcribed LckR_FRET mRNA. 
Jurkat cells were stably transfecting LckR_FRET. After fixing, images were acquired for both 
donor and acceptor fluorescent proteins in TIRF with a 480nm excitation. The FRET ratio for 
activated Jurkat was 0.424 ± 0.203 (mean ± standard deviation). And the FRET ratio for PP2 
preincubated Jurkat was 0.320 ± 0.140 (mean ± standard deviation) (Fig. 2.9). The differences 
were statistically significant (p = 0.012).  
 
Figure 2.9: The effect of PP2 on LckR_FRET biosensor.  Box and whisker diagram of FRET ratio for Jurkat cells 
transfected with LckR_FRET. P < 0.05. 
2.4 Discussion 
Two fundamentally different approaches can be used to study Lck dynamics. One focuses on the 
phosphorylation states of the regulatory tyrosines, and another on the Lck kinase activity. Typical of its 
family, Lck kinase activity is highly regulated by its conformational changes. And the protein exists in 
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four different states as defined by the phosphorylation states of its two regulatory tyrosines: 
autoinhibited (pY505), primed, active (pY394), or DPho-active (pY505 and pY394). Stirnweiss and 
colleagues approached the study of Lck dynamic with a conformational FRET reporter. Unfortunately, 
the reporter does not distinguish between the 4 different states. It merely reports on either an open 
(likely active) or a closed (likely autoinhibited). The reporter observed a 20% increase in the ‘open’ form 
upon CD3 engagement, an increase from 16% to 19.2% in JCAM1.6. As mentioned, under unstimulated 
conditions, 16% of the Lck protein is already pY294-active. That’s not including a large population of 
DPho-active Lck proteins. As a reference, in Jurkats, before stimulation 23% of Lck proteins are pY394-
active and 29% DPho-active. So the additional 20% increase in pY394 at the plasma membrane, what 
does that mean for intracellular kinase activity? The conformational reporters offered no additional 
information.  
Thus a reporter of Lck kinase activity was designed. PLck phosphorylation of the substrate peptide would 
trigger a FRET response. Fragments of the ZIP reporter from the Vale group were salvaged to generate 
the LckR_FRET reporter. However, different methods were employed to quantify the FRET responses. 
The Vale group measured the lifetime of the eGFP in fixed samples: to quantify how eGFP lifetime 
shortens in response nonradiative energy transfer to mCherry. To capture real-time FRET responses, 
another method was used, measuring the acceptor, or mCherry, intensity versus the donor, or YPET, 
intensity. As discussed in the introduction, beyond conformational regulations, spatial organizations of 
pLck during IS formation also plays an important role on the overall effect of Lck kinase activity. Thus, a 
real-time reporter would be more appropriate to study the interactions. The next chapter focuses on the 
challenges of working with primary T-cells and studies in Jurkats to understand how CD3 and CD28 





3. The LckR_FRET Reporter  
3.1 Introduction 
LckR_FRET must first be transfected into the cells. And many factors affect transfection, such as 
cell type, cell growth cycle, and osmotic conditions of the transfection media.  T-cells, central to 
immune response to foreign pathogens, are naturally intolerant of transfections. Naïve T-cells 
are even more difficult to work with because they are metabolically resting before activation. 
And actively dividing cells take up genetic materials more readily than quiescent cells.  
Investigators have generally utilized viral transduction, especially lentiviral vectors for both 
dividing and non-dividing cells. Even then, T-cells first must be stimulated to activate and to 
divide generating lymphoblasts. And human peripheral blood CD4+ T-cells and mouse splenic 
CD4+ T-cells respond differently to CD3 and CD28 engagement after stimulation. Beyond the 
need to stimulate T-cells, viral transduction is very labor, time, and cost intensive. Even upon 
successful transduction, cells infected with lentivirus are difficult to work with, as 
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environmental stresses will trigger the virus to go lytic, and kill-off the host cell. Finally, there 
are the safety concerns of working with a retrovirus, which requires P2 containment. (Zhao, 
Zheng et al. 2006). Ultimately, non-viral gene transfer was opted for the LckR_FRET reporter.  
It is still a real challenge to modify primary T-cells using non-viral gene transfer. The most 
common method is electroporation; the exposure of an intense electric field transiently 
permeabilizes the cellular membrane. This was the method used by Bashour to study the 
diffusion of Lck_YFP. The method had low gene transfer efficiency and poor viability due to 
cytotoxicity. However, the only method available for primary T-cells without stimulation. To 
illustrate the challenge, Bashour transfected T-cells with Lck_YFP to measure its diffusion rate 
within human and mouse T-cells. The diffusion rate were measured using less than 30 cells. To 
put into perspective, Bashour completed more than a dozen rounds of transfection to collect 
the data. And for each round of transfection, a suspension of roughly 10 million T-cells were 
used. While highly inefficient, the method gave wonderful insight into Lck dynamic in clinically 
relevant cells.  
The difficulty of working with primary cells also forced many researchers to use lymphoblastic 
cells line, the mostly commonly used T-cell lines to study Lck dynamics are the Jurkat cells and 
its variants. However, Jurkat cells have corrupt signaling pathways when compared to health, 
non-cancerous lymphocytes. Ueda and colleagues were studying the effect of CD28 
engagement by B7-2 or CD85 on phosphoinositide 3-kinase (PI3K) activity (p85-p110 
heterodimer) and its downstream effect on IL-2 secretions (Ueda, Levine et al. 1995). PI3K 
catalyzes the conversion of phosphatidylinositol (4,5)-bisphosphate (PIP2) to 
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phosphatidylinositol(3,4,5)-triphosphate (PIP3). Thus, to measure PI3K activity, PIP3 
concentration was quantified.  And to capture the dynamics of the pathway, Wortmannin, a 
pharmacologic inhibitor of PI3K was used.  
In Jurkat cells, while Wortmannin inhibited PIP3 in a concentration dependent manner (Fig. 
3.1A), it increased IL-2 secretions (Fig. 3.B).   
 
Figure 3.1: A. Wortmannin inhibition of B7-2 induced PIP3 conversion was concentration dependent. B. 
Wortmannin, despite PIP3 inhibition, resulted in increased IL-2 secretion. From (Ueda, Levine et al. 1995). 
In contrast, in primary human T-cells, Wortmannin inhibits both PIP3 and IL-2 (Fig. 3.2). Jurkat 
cells were sensitive to CD28 engagement; however the functional pathways appeared to be 
different from primary T-cells, thus emphasizing the importance of working with primary cell. 
 
Figure 3.2: Wortmannin inhibition of IL-2 secretions in primary T-cells. From (Ueda, Levine et al. 1995).  
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3.2 Materials and Method 
3.2.1 Micropatterned Glass Preparation 
Glass coverslides were prepared as previously described. To create micropatterned surfaces, 
stamps were incubated in a solution with a total protein concentration of 28 μg/mL. For mouse 
T-cells, activating antibodies against CD3 (clone 145-2C11) and CD28 (clone 37.51) were 
purchased from eBioscience. The stamped surfaces were backfilled with mouse ICAM-1 (R&D 
Systems CD54 Fc Chimera Protein) to promote adhesion at 2 μg/ml for 2h. For human T-cells, 
activating antibodies against CD3 (clone OKT3 from M Sheetz’ laboratory, Columbia University) 
and CD28 (clone 9.3 from BioXCell, BE0248). L were also purchased. Again, the surfaces were 
backfilled with human ICAM-1 (R&D Systems CD54 Fc Chimera Protein) at 2 μg/ml for 2h. 
For COL pattern, stamps with 2μm diameter dots at either a 10µm pitch for mouse T-cells or a 
15µm pitch for human T-cells were used. The incubation mixtures for the stamps were made at 
1:10 (wt/wt) -CD3:-CD28 for mouse T-cells, and 1:3 (wt/wt) -CD3:-CD28 for human T-
cells. 
For SEG pattern, an inert antibody was used to standardize the total protein concentration. In 
this case, donkey anti-sheep IgG (Life Technology A16045) was used. And two rounds of 
stamping were performed to generate the pattern. First, stamps with 2μm diameter dots were 
incubated with -CD:-IgG at either 1:10 or 1:3, depending on the species of the primary T-
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cells. Next, stamps with 1μm diameter dots at a 5µm pitch were incubated with -IgG: -CD28, 
again at either 1:10 or 1:3.  
Adjustments were made for Jurkat cells because of the large cell size. Stamps with 2μm 
diameter dots and a 15µm pitch were used for the -CD3 antibody. And stamps with 2μm 
diameter dots and a 10µm pitch were used for the -CD28 antibody. Human ICAM-1 was 
eliminated because Jurkat cells do not require adhesion proteins to land and spread. 
3.2.2 T-cell Isolation 
Mouse T-cells were collected from the lymph nodes and spleens of 6-week old C57BL/6 males. 
CD4+ T-cell isolation was performed with negative-selection Dyno beads (Invitrogen, 11415D), 
which gave predominately naïve mouse T-cells (Bashour, Tsai et al. 2014). Human CD4+ T-cells 
were purified from Leukopacks (New York Blood Center) using negative selection Rosette-Sep 
kits (StemCell Technologies 15062). The purified T-cells were a mixture of naïve and memory 
cells (though higher percentages of the population were naïve T-cells), and highly patient-
dependent.  
All the cells were cultured in RPMI 1640 (Gibco 32404), supplemented with 10% FBS, 10mM 
HEPES, 50 U/mL Penicillin & Streptomycin, 2mM L-glutamine, and 50µM -Mercaptoethanol. 
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3.2.3 Nucleic Acid Transfection 
Electroporation was performed using two commercial systems: Neon Transfection System 
(Invitrogen) and Amaxa/Nucleofector Technology (Lonza). Because of poor transfection 
efficiency and viability of T-cells, in vitro transcribed LckR_FRET mRNA was used for gene 
transfer instead of DNA plasmid. Also, naïve T-cells without stimulation cannot survive 
overnight, which is needed for an incorporated DNA plasmid to express a protein of interest. 
Neon had recommended or optimized settings for Jurkats. Unfortunately, none were available 
for unstimulated human and mouse primary T-cells. Optimization protocols were performed 
without much success (see discussion below). 
Amaxa offered an optimized protocol for C57BL/6 unstimulated splenocytes. For the control 
plasmid, (pMAX-GFP), Lonza reported the viability at 35% and with only 20% transfection 
efficiency using program X-001. When transfecting LckR_FRET mRNA, the cytotoxicity and 
transfection efficiency were even worse. Discussion with Lonza technical support yielded no 
further progress as they suggested either stimulate the naïve T-cells to generate lymphoblasts 
or switch to viral transduction. Amaxa also offered an alternative protocol for unstimulated 
human peripheral blood T-cells: program V24. While GFP mRNA was efficiently transfected, the 
cells did not tolerate LckR_FRET, a much larger construct. 
Post transfection, T-cells recovered for 5 h in prewarmed fully supplemented media (see above) 




Immunostainings were performed in Jurkat cells to study pLck distribution. The Jurkat cells 
were seeded onto the micropatterned surface for 30 minutes, fixed with 1:1 4% 
paraformaldehyde: PHEM buffer for 15 minutes, and perforated with 0.1% Triton-X in PBS. 
Next, the cells were blocked 2h to overnight with 5% BSA. Then primary staining was performed 
at 1:200 dilution using antibodies targeting phosphorylated Lck Y394 (Novus Biological NBP1-
60894). Finally a secondary staining was performed at 1:500 dilutions against pLck (AF488 α-
rabbit) before washing and imaging.  
3.2.5 IL-2 Secretion Assay 
IL-2 secretion assays performed used to measure T-cell activation at a medium time-scale. IL-2 
was indirectly captured using an IL-2 secretion kit (Miltenyi 130-090-763 or 130-090-987). The 
IL-2 binding antibodies were mounted onto CD45, a protein ubiquitously expressed on T-cells. 
The mounting of -IL-2 antibodies was performed per the manufacturer’s recommendation. 
However, adaptations were made to the manufacturer’s protocol because the kit was intended 
for FACS analysis for cells in a suspension buffer, instead of adherent cells on a coverslide. 
Instead, T-cells were seeded onto micropatterned glass surfaces, and maintained under 
standard cell culture conditions for 6h. Next, detecting agent was added to examine IL-2 
secretion on a cell-to-cell basis. Finally, the cells were fixed for imaging. IL-2 secretion was 
captured using 20x objective and quantified using MetaMorph; IL-2 fluorescent intensity was 
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measured for at least 200 cells per condition, and for each cell the intensity was averaged 
around the whole cell.  
3.2.6 FRET Measurement and Analysis 
Image acquisitions were completed as previously described. And FRET Analysis was adopted 
from Na and colleagues (Na and Wang 2008) as described in Chapter 2.  And custom Matlab 
codes were written to process the timelapse images. See Appendix A 
Without a beam splitter, donor and acceptor images were acquired within 1s of each other. 
Diffusion of Lck is roughly 0.26 μm2/s in Jurkat cells that’s Lck-deficient (Zimmermann, Paster et 
al. 2010). Since D = x2/4T (D – diffusion, x – distance, and T-time), at 100X (.08μm/pixel) it’s a 
13-pixel movement. 
During timelapse imaging, interval of acquisition must balance photobleaching of the 
fluorescent proteins against the time scale of pLck diffusion between CD3 and CD28. With an 
acquisition interval of 30 seconds, the Lck protein would have diffused roughly 5.5μm.  
3.3 Results 
3.3.1 Transfection of Mouse Splenocytes 
Non-viral gene transfer of LckR_FRET requires in vitro transcribed mRNA. The Neon 
Transfection System was selected over the Amaxa Nucleofactor System. Neon permits a 
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reaction volume ~10µl; in comparison, Amaxa requires a 100µl reaction volume. Instead of 
using 2-4µg of LckR_FRET mRNA per reaction, Amaxa required +40µg, an unsustainable amount 
given the limitations of the in vitro mRNA production system. 
The Neon Transfection System did not provide an optimized setting for unstimulated mouse 
primary T-cells. Thus, an optimization protocol was performed initially using GFP mRNA before 
switching to LckR_FRET mRNA. Five parameters were optimized: cell density, mRNA 
concentration, pulse voltage, pulse width, and number of pulse. All of which affected 
transfection efficiency and cell viability.  
Table 3.1: Optimization of transfection parameters for mouse splenocytes 














e A 1,000,000 2 500 20 1 
B 1,000,000 2 750 20 1 














t A 500,000 2 750 20 1 
B 500,000 4 750 20 1 






















A 1,000,000 4 750 20 1 
B 1,000,000 4 750 30 1 
C 1,000,000 4 750 30 2 
D 1,000,000 4 850 30 1 
E 1,000,000 4 950 30 1 
 
Jurkats were used (Neon recommended setting available) as a control for LckR_FRET mRNA 
quality and cellular transfection (Fig. 3.3 Jurkat control). Initial reactions found that at a low 
voltage (i.e., 500mV), the T-cells exhibited good viability, but a poor transfection efficiency. On 
the other hand, high voltage (i.e., 1000mV) resulted in very poor viability (Fig. 3.3).  
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Figure 3.3: Representative images of transfected mouse splenocytes. Images were taken in Brightfield, 
interference reflection microscopy (IRM), and epifluorescence (for GFP). IRM reports cellular adhesion, a good 
indicator of cellular viability. Red arrows point to apoptotic cells. Scale Bar = 10µm. 
Next, an optimal mRNA concentration (4µg) and cell count per reaction (1M) was found. While 
750mV pulse voltage gave good viability, its transfection efficiency was very poor (<10%). Small 
increases in pulse voltage, width, and number did not greatly increase the transfection 











eGFP mRNA was replaced with LckR_FRET mRNA. Viability further decreased and no 
transfected cells were observed. Discussions with Invitrogen technical support were unfruitful. 
They suggested moving into a lentiviral transduction system.  
Despite the limitations of the in vitro mRNA production system, the study moved into the 
Amaxa/Nucleofector Technology system. Unlike the Neon system, where users can control up 
to five parameters, Amaxa gives pre-programmed protocols with a set cell count and a small 
range of recommended mRNA concentrations. Initially reactions with GFP mRNA were 
completed using the recommended program, X-001. While transfection of GFP mRNA was 
possible, LckR_FRET mRNA had very poor transfection efficiency and viability (Fig. 3.4). 
Technical support at Lonza suggested two alternative programs, U-001 and W-001. Again, 
transfection was possible with GFP mRNA, but not LckR_FRET mRNA, a construct that roughly 
three times as large as the control. 
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Figure 3.4: Representative images of transfected mouse splenocytes. Images were taken in Brightfield, IRM, and 
epifluorescence (for GFP or YPET and mCherry). Mouse spleenocytes tolerated GFP, but not LckR_FRET.  Scale 
Bar = 10µm. 
3.3.2 Transfection of Human T-cells 
Again, the Neon Transfection System did not provide an optimized setting for unstimulated 
human peripheral blood T-cells. Thus another optimization protocol was performed.  
Table 3.2: Optimization of transfection parameters for human peripheral blood T-cells 














e A 1,000,000 2 1325 20 1 
B 1,000,000 2 2050 20 1 











  A 1,000,000 2.00 2100 20 1 
B 1,000,000 2.75 2100 20 1 
C 1,000,000 3.50 2100 20 1 
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Figure 3.5: Representative images of transfected human peripheral blood CD4+ T-cells. Images were taken in 
Brightfield, IRM, and epifluorescence (for YPET and mCherry). While transfection was achieved at 2200mV and 
3.5µg of mRNA, the cell was not viable as seen in IRM. Scale Bar = 10µm.  
Using GFP mRNA, 2100mV was found to be an appropriate pulse voltage. GFP was replaced 
with LckR_FRET mRNA. At 2µg, the viability was acceptable, but with poor transfection 
efficiency. Unfortunately upon addition of more mRNA (3.5µg), the viability vastly decreased 
(Fig. 3.5). Lonza representatives again recommended using lentiviral systems.  
Again the study moved into the Amaxa/Nucleofector Technology system. Initial optimization 
were completed in recommended program V-24. While the cellular viability was satisfactory, 
the transfection efficiency was poor. To compensate for the poor transfection efficiency, 
additional mRNA were added. Instead of the recommended 1-5µg of plasmid, 16µg of 
LckR_FRET mRNA were added. While the transfection efficiency increased slightly with the huge 
increase in LckR_FRET mRNA concentration, the cells were still too dim for imaging and 
subsequent analysis. 
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Figure 3.6: Representative images of transfected human peripheral blood Cd4+ T-cells using the Amaxa system. 
Images were taken in Brightfield, IRM, and epifluorescence (for GFP or YPET and mCherry). Despite a large 
quantity of LckR_FRET mRNA, the transfection efficiency was still poor. Scale Bar = 10µm. 
3.3.3 Jurkat Cells Are Responsive to Micropatterned Surfaces 
Unable to transfect primary T-cells with LckR_FRET, the study moved back into Jurkat cells. And 
the T-cell line does have a compromised signaling cascade, as demonstrated by the 
Wortmannin study. However, the LckR_FRET reporter probes Lck kinase activity, which occurs 
very early in the signaling cascade, within the first 30 minutes after T-cell activation. Even the 
Wortmannin study suggested that early enzymatic activities (i.e., PI3K activity) were less 
compromised in Jurkat cells.  
Before continuing onto dynamic real-time imaging and analysis of Jurkat cells responding to 
microscale spatial cues, previous studies were replicated in the T-cell line, as performed prior in 
human and mouse primary T-cells.  
Initially, immunostainings were performed to understanding the time scale of Lck activation in 
Jurkats. And it was found that when compared to mouse T-cells, pLck signaling was more 
sustained in Jurkat cells. In mouse T-cells, pLck staining peaked around 5 minutes and 
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disappeared after 15 minutes (Lee, Holdorf et al. 2002). However, in Jurkats, pLck staining was 
still visible after 15 minutes, and mostly disappeared after 30 minutes. In conclusion, an 
appropriate duration for a timelapse to study LckR_FRET reporter in Jurkats would be roughly 
15 minutes.   
 
Figure 3.7: A. Mouse transgenic splenic T-cell were activated by APCs from B10.BR mice. From (Lee, Holdorf et al. 
2002). B. Jurkat cells were seeded onto activating surfaces. All the cells are fixed at the indicated time, 
perforated, blocked and stained with pLck.  
Next, IL-2 secretion assays were performed to measure cellular response to micropatterned 
surfaces. As mentioned in Chapter 1, mouse T-cells prefer SEG pattern to COL pattern; 
specifically the cells favor peripheral presentation of CD28 (Fig. 3.8A). In contrast, human 
peripheral blood CD4+ cells respond strongly to COL pattern because IL-2 secretions require co-
engagement of CD3 and CD28 (Fig. 3.8B). Like non-leukemic primary T-cells, human 
lymphoblastic Jurkat cells also require CD28 for IL-2 secretion, as evident by the lack of 
response on -CD3 surfaces. However, unlike both human and mouse primary T-cells, for 
Jurkats, adhesion and spreading are uncoupled from cellular activation and costimulation. 
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While few primary T-cells could be found on -CD3 surfaces, Jurkat cells readily adhere without 
IL-2 secretion. Like primary human T-cells, stronger IL-2 secretion was observed on COL 
micropatterns, 1.5x fold increase over the intensities observed on SEG surfaces. However, 
unlike human primary cells, Jurkat cells had significant IL-2 secretion on SEG surfaces, about 
100 fold brighter in intensity than on CD3 surfaces (p<0.0001).  
 
Figure 3.8: Cellular response to micropatterned surface. A. mouse splenocytes favored peripheral presentation 
of CD28. From (Shen, Thomas et al. 2008). B. Human peripheral blood lymphocytes favored co-presentation of 
CD3 and CD28. From (Bashour, Tsai et al. 2014). C. Jurkat cells, while like human primary cells responded most 
strongly to COL surfaces, had significant IL-2 secretion on SEG patterns. 
Previous work in our lab partially attributed the observed differences between human and 
mouse T-cells on differential Lck diffusion between the species. In mouse T-cells, rapid diffusion 
(0.37μm2/s) of pLck was able to overcome the basal phosphatase activities, resulting in 
scattered distribution of pLck (Fig. 3.8) and stronger IL-2 secretion on SEG patterns. However in 
human T-cells, Lck diffused much slower (0.04 μm2/s). The pLck distribution favored CD3, and 
any significant IL-2 secretion required CD3/CD28 co-engagement. For Jurkat cells, Lck diffusion 
was measured to be 0.26 μm2/s (Zimmermann, Paster et al. 2010); the rate was closer to that of 
mouse T-cells. This could explain the significant secretion of IL-2 on SEG micropatterns. The 
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rapid diffusion of Lck permitted responsiveness to the SEG surface. However, the phosphatase 
activities could ultimately limit the overall pLck kinase activity. Thus immunostaining of Jurkats 
on different micropatterned surfaces more closely resemble that of human primary T-cells (Fig. 
3.9). In Jurkats, pLck preferentially localizes to CD3. However, a low concentration of pLck could 
be found throughout the interface. On COL pattern, Jurkat cells center on CD3-CD28 dots. 
However, on SEG patterns, a small population of cells does not center on CD3 dots. And neither 
does the pLck staining, instead, the concentrated cluster of pLck protein is found off the -CD3 
surface at the center of the cell (Fig. 3.9), a phenomenon which will be discuss in detail later. 
 
Figure 3.9: PLck staining of mouse naïve T-cells, human primary T-cells and Jurkat cells. While pLck was found 
throughout the mouse T-cell –glass interface, pLck preferentially co-localize with CD3 in human primary cells. 
From (Bashour, Tsai et al. 2014). In human lymphoblastic cell line, Jurkat E6.1, pLck also favored CD3. However, 
there existed a low concentration of pLck throughout the cell-glass interface.  
3.3.4 LckR_FRET reporter in Jurkat cells 
Jurkat cells were transfected with LckR_FRET mRNA. A few parameters were optimized for 
biologically relevant data acquisitions. Without a beam splitter, donor and acceptor spectra 
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emissions were measured sequentially. Given the diffusion rate of pLck (0.26 μm2/s), 
acquisition was completed under 1s total, equivalent of about 13 pixel shift.  
Next, during timelapse imaging, interval of acquisitions must balance the photobleaching of the 
fluorescent proteins against the diffusion of the Lck proteins. Given the diffusion rate of Lck in 
Jurkats, a time interval of 30s was selected. In 30s, Lck would have traveled roughly 5.5µm. 
With a 2µm -CD3 dot at the center of an array of 2µm -CD28 dots with a 10µm pitch, the 
distance between -CD3 and -CD28 is roughly be 7.1µm.  
The acquisition technique over-bleaches the donor.  For a given time point, YPET is exposed 
twice to a 450nm excitation laser, in order to measure both YPET and mCherry emissions. Wang 
and colleagues were able to correct for the photobleaching. For the Src FRET reporter, because 
no Src proteins were expressed in the nucleus, the averaged intensity of the region was used to 
normalize the subsequent time points. Unfortunately, Lck is found throughout the cell-glass 
interface. To limit the effect of photobleaching, the duration of timelapse imaging was limited 
to roughly 15-25 minutes. Also immunostainings revealed that pLck signaling already started to 
disappear 15 minutes after activation (Fig. 3.7).  
Beyond a corrupt CD28 signaling pathway (Ueda, Levine et al. 1995), Jurkats behave very 
differently from primary human T-cells. Primary T-cells are cultured in suspension. TCR/-CD3 
engagement acts as a stop signal to leave the suspension and adhere onto surfaces. Without 
CD28 co-stimulation, the primary T-cells rapid disengage. Even with CD28 co-stimulation, but 
without ICAM-1 engagement, the T-cells form poor contact and fail to spread. And either CD28 
78 
 
or ICAM-1 can induce T-cell activation and subsequent adhesion, independent of CD3 priming. 
In contrast, unstimulated Jurkat cells readily adhere to untreated glass surfaces. And cellular 
adhesion to glass surfaces also induces low level of Lck activation (as revealed by pLck 
immunostainings).  
Because Jurkats readily adhere to glass surfaces, it was difficult to capture cells landing and 
responding to micropatterned protein dots, as the proteins occupy a small percent of the total 
surface area.  Starvation regiments were performed to suppress the basal metabolic rate as 
suggested by literature, and in an effort to suppress non-specific adhesion-induced Lck 
activation. Shan and colleagues cultured Jurkat overnight in 2.5% FBS media (Shan, Czar et al. 
2000). August and colleagues serum starved the cells in 0.5% FBS media for 4h (August and 
Dupont 1994). Chu and colleagues starved Jurkat cells for 2h in serum-free RPMI 1640 (Chu, Wu 
et al. 2004). Despite trying the different resting regiments, pLck immunostainings revealed 
robust activation of Lck, independent of CD3 or CD28 engagement.  
Efforts were made to quantify pLck kinase activity in cells that landed between the 
micropatterened protein dots, also referred to as ‘null’ cells. Two populations of null cells were 
observed. Some null cells land and spread onto glass without ever coming into contract with 
micropatterned protein dots (Fig. 3.11A). Others land and repeatedly attach and detach, or 
bounce on the glass surfaces (Fig. 3.10).  And FRET ratios were calculated on a pixel-to-pixel basis 





Figure 3.10: Plots of a representative null cell bouncing on the glass surface. The cell is not in contact with any 
micropatterned proteins ( trace of the closest micropatterned dot). And the FRET ratio is sensitive to cells stepping on 
and off the glass surface. 
Null cells that bounce on the glass surfaces help to illustrate that the FRET ratio is sensitive to 
cells stepping on and off a ROI. While the FRET ratio had a small dynamic range (Fig. 2.9), 
artificially high FRET ratios were produced from the highly ambulatory null cells (Fig. 3.10B). 
Thus the bouncing null cells were excluded from the analysis. 
Another limitation elucidated by Fig. 3.10 is seen in traces for the ROI on the -CD3 dot. While 
neither donor nor acceptor intensities were captured, as an artifact of the FRET analysis, high 
FRET ratio was generated by the background noises, as seen in the traces for ROI-CD3. It can 
also be inferred that cells with low level of LckR_FRET expression will also produce artificially 
high FRET ratios. Thus these cells were also excluded from the analysis.  
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Null cells also simply land and spread (Fig. 3.11A). Unsurprisingly, the FRET ratio of the non-
ambulatory null cells varies minimally. Then the FRET ratios were averaged from after the cells 
land (~1-3 minutes) and to before photobleaching (~15 minutes) generates artificial high ratios.  
The average FRET ratio for non-ambulatory null cells was 0.522  0.177 (mean  stdev).  
     
         
Figure 3.11: A. Plots of a representative null cell landing and spreading on the glass surface. Again the cell is not in contact 
with any micropatterned proteins ( closest micropatterned surface). B. FRET ratio traces of null cells.  
Another large population of seeded Jurkat cells, interact with micropatterned protein dots 
intermittently (Fig. 3.12). And like null cells bouncing on the glass surface, artificial high ratios 
were generated. Thus these cells were also excluded from the analysis. 
 
Figure 3.12: A cell interacting intermittently with the micropatterned proteins ( CD3-dot).  
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For cells that consistently interact with the micropatterned dots, three types of surfaces were 
studies: -CD3 only surfaces, COL surfaces, SEG surfaces. Again, only few cells were captured 
on these three surfaces, once the nulls and the partially interactive cells were eliminated. For 
Jurkats seeded on CD3 micropatterned surfaces, the average FRET ratio was 0.576  0.251 
(mean  stdev).  
On COL surfaces, if cells land and find the micropatterned proteins, they tended to spread 
around the protein dots for sustained contact with the surface (Fig. 3.13A). While CD3-CD28 co-
engagements are not necessary for surface adhesion, upon contact with the protein dots, the 
region becomes a site for sustained high pLck kinase activity. Fig. 3.13A shows a typical Jurkat 
cell landing on COL surfaces. Upon being in contact with the -CD3/-CD28 dot (T = ~1 min), 
the cell spread onto the dot. FRET ratio heat map revealed that the pLck kinase activity was 
very strong throughout the cell upon initial landing and spreading. Then after about 7 minutes, 
pLck activity dropped off across the interface, except on top of the -CD3 protein dot (Fig. 
3.13B). And the prolonged contact with the protein dots resulted in average FRET ratios with a 
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Figure 3.13: Montage of a Jurkat cell interacting with a COL micropatterned glass coverslide. A. Only the donor 
(YPET) intensity was shown. B. Heat map of FRET ratios. Scale bar = 5µm. 
However, Jurkat cells behave very differently on SEG surfaces. The cells were more migratory. 
And sometimes, Jurkat cells simply spread out away from the -CD3 dots and interact with the 
proteins with its lamellipodia (Fig. 3.14).  
 
Figure 3.14: Plots of a representative cell on a SEG surface. The cell landed onto the surface. At around T = 5 min, 
it came into contact with the -CD3 dot ( ). Then the cell sustained the contact with a varying degree of 
intensities, depending on the size of the lamellipodia.  
Again, Jurkats readily land and spread without CD3 engagement, which induce an increase in 
FRET ratio across the cell. However, the heightened pLck activity quickly disappears after about 
4 minutes. Around T = 5 min, the cell comes into contract with the -CD3 proteins. The CD3 
engagement, induces the classic centripetal retrograde flow, associated with immunological 
synapse formation (Fig. 3.15A T = 10-25 min). Correspondingly, an increase in FRET ratio is 
observed at the center of the cell (Fig. 3.15B T=10-25 min). And this could explain the cells 
observed in fixed pLck immunostainings where the concentrated dot of pLck proteins was 
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Figure 3.15: The same representative cell from Fig. 3.14 on a SEG surface. The cell landed and began to spread. 
At around 10min, contact with -CD3 dot initiated centripetal retrograde flow. A. Montage of a Jurkat cell on 
SEG patterns, with green for YPET intensity and red for mCherry intensity. B. Heat map of FRET ratio. Scale bar = 
5µm. 
The FRET ratios were averaged from after the cells land contracted both CD3 and CD28 dots, 
and for 10 minutes afterward. However, because of photobleaching from longer timelapse 
imagings (takes longer to land, then locate both CD28 and CD3 proteins), the FRET ratios 
steadily rose. And the average FRET ratios reflected the effect: 0.662  0.095(mean  stdev). 
 
Figure 3.16: FRET ratios of Jurkat cells on micropatterned surfaces: null, CD3, COL, and SEG. The differences were 
statistically insignificant.  
Comparing the average FRET ratios across the different micropatterned surfaces, they were not 
statistically significant (Fig. 3.16). However, downstream assays measuring IL-2 secretions 
revealed differences in cellular activation on the three surfaces (Fig. 3.8). Two probable 
explanations emerged. One, the dynamic range for the LckR_FRET reporter was insufficient in 
teasing out the differences. The problem was further aggravated by variations in LckR_FRET 
expression levels and cellular movement. Two, while the magnitude of the pLck kinase activity 
was the same among the surfaces, the duration could be different. Unfortunately, in an effort 
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to minimize photobleaching, longer duration of image acquisition was not considered. Another 
construct was designed to capture the duration of the pLck kinase activity. Its design and 
synthesize are detailed in the next chapter. 
3.4 Discussion 
Activation and expansion of primary T-cells for adoptive immunotherapy have always 
motivated the research from our laboratory. Beyond using chemical and biological cocktails to 
induce the desired cellular responses, this thesis aims to understand how spatial cues can 
modulate T-cell activation. To be clinically relevant, attempts were made to transfect 
LckR_FRET into primary T-cells. However, the endeavor was stymied by technical challenges. T-
cell, as a master regulator of immune responses against foreign pathogen, was extremely 
resistant to gene transfers. Gene uptake mimics a viral infection, thus most methods induced 
tremendously level of T-cell death. And despite performing multiple rounds of optimization 
protocols in the Neon Transfection System and exploring alternative programs in the Amaxa 
system, the efforts ultimately failed. 
LckR_FRET was ultimately transfected into Jurkat cells. The T-cell lines does have a 
compromised signaling network, as demonstrated by the Wortmannin study. However, the 
LckR_FRET reporter focus on Lck kinase activity, which occurs very early in the signaling 
cascade. And Wortmannin study seems to suggest that early enzymatic activities were less 
compromised (i.e., PI3K activity). Unfortunately, Jurkat, a human lymphoblastic cancerous T-cell 
line, behaves very differently from primary T-cells. Human T-cells remain in suspension, until 
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CD3 engagement, which acts as a stop signal. And the cell lands and adhere to the surface. 
Without CD28 costimulation, the cell would rapidly disengage. And even with both signals, 
ICAM-1 binding with LFA-1 is crucial for a stable interaction, aiding the cell in forming a tight 
seal around the IS and spread out across the interface. In contrast, Jurkat cells readily adhere 
without CD3-induced activation. Still IL-2 secretion assays revealed that Jurkat cells require 
CD28 engagement for a robust activation. Because Jurkats readily adhere to glass surfaces, it 
was a challenge to capture cells landing and responding to micropatterned protein dots, as the 
proteins occupy a small percent of the total surface area.   
Nonetheless, few interesting observations were made. Upon Jurkat cell spreading, Lck was 
activated throughout the interface. On COL surfaces, most of the pLck kinase activity dropped 
off after roughly 7 minutes. Heightened activity remained on top of the α-CD3/α-CD28 dots. On 
SEG surfaces, again, pLck activity increased upon spreading, within minutes, the activity all but 
dropped off. Upon contact with α-CD3 dots, FRET ratio again increased, and the classic 
centripetal retrograde flow was observed, with heightened pLck activity concentrated at the 
center of the cell.  
However, analysis of average FRET ratios revealed no differences among the various surface 
conditions. Immediately, limitations of the FRET reporter and the analysis were examined. It’s 
possible that the LckR_FRET reporter lacks the sensitivity to differentiate the FRET responses. 
This is further complicated by the susceptibility of the FRET ratios to variation in LckR_FRET 
expression levels and cellular movement. Another possibility is that pLck activity is similar 
during the interval, but changes afterward. FRET ratios were averaged for the first 15 minutes, 
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to compensate for the inability to correct for photobleaching. Thus, not just the magnitude, but 
also the duration of pLck activity should be examined. In an effort to address some of these 







4. The Tandem SH2-Domain 
Recruitment Reporter  
4.1 Introduction 
With the Lck membrane targeting peptides at the N-terminus, the LckR_FRET reporter moves 
with the protein to report on total Lck distribution throughout the surface. And the FRET 
responses help to isolate spatial regions of high pLck kinase activity. For Jurkat cells, high pLck 
kinase activity is localized to the center of the cells, and for COL surfaces on top of the -
CD3/-CD28 dots.  However, there are limitations to the LckR_FRET reporter. For one, the 
dynamic range of the probe is quite small. For some cells, no regions of high pLck kinase activity 
was observed when examining the FRET ratio color maps. Also, unable to correct for 
photobleaching, FRET ratios started to artificially creep up, about 20 minutes after cellular 
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activation. Another construct was designed to probe pLck kinase activity. The new probe 
exploits the dynamic interactions induced by Lck activation. CD3, a receptor ubiquitously 
expressed on surface of Jurkats. Upon Lck activation, its ITAMs are phosphorylated, inducing 
the recruitment of ZAP70, through its tandem SH2-domain. (Fig. 4.1A).  
Zap70 is a Syk-family protein tyrosine kinase (PTK). Its expression is predominately limited to 
thymocytes and peripheral T-cells (Au-Yeung, Deindl et al. 2009); in contrast, other PTKs 
involved in T-cell signaling are more ubiquitously expressed in various types of immune cells. 
Upon phosphorylation of the crucial tyrosines, Zap70 is recruited by the doubly phosphorylated 
ITAMs. The recruitment not only localizes Zap70 to CD3 for pLck to activate the protein, but 
also relieves the autoinhibited conformation of Zap70.  Two critical downstream adaptor 
proteins are then phosphorylated: linker for activation of T-cells (LAT) and SH2-domain 
containing leukocyte phosphoprotein of 76kDa (SLP-76). The downstream signaling cascade 
results in cytokine production, T-cell differentiation and differentiation. Clinically Zap70-
deficient patients suffer from severe combined immunodeficiency (SCID), while Zap70 
hypermutation has been associated with poor prognosis in leukemia. Also because Zap70 has 






Figure 4.1: A. Zap70 recruitment upon Lck activation. The tandem SH2 domains are recruited to the pITAM. B. 
Schematic of Zap70 protein: tandem SH2-domain, interdomain B with crucial regulatory tyrosines, and kinase 
domains. From (Au-Yeung, Deindl et al. 2009).  
Structurally, Zap70 has two SH2-domains (linked by interdomain A) and a C-terminal kinase 
domain. Between which is interdomain B containing 3 critical regulatory tyrosines (Fig. 4.1B). 
Y292 is associated with autoinhibition, while Y315 and Y319 are showed as positive regulators 
in mutational analysis. Without a membrane-targeting domain, the tandem SH2-domains are 
responsible for Zap70 recruitment. And both domains are necessary for high avidity binding; it 
insures preferential accumulation at the pITAMs, instead of other singly phosphorylated sites.  
Bunnell and colleagues studied T-cell activation with eGFP tagged proteins (Bunnell, Hong et al. 
2002). At one point during the study, they examined full-length Zap70_eGFP in Jurkat cells on 
glass coverslides coated with -CD3 antibodies. Zap70 was initially recruited to the surface in 




Figure 4.2: A. Zap70 recruited to TCR in tight contact with the surface, as seen in IRM imaging. And the 
recruitment occurred within 15s. B. The signal persists without moving laterally. From (Bunnell, Hong et al. 
2002).  
Zap70 signal persisted for at least 20min without moving laterally, uncoupling from the TCR, 
which has migrated to the cSMAC (Fig. 4.2B). FRAP studies of Zap70_eGFP revealed that the 
bleached region recovered rapidly, indicating a rapid equilibration between bleached and 
unbleached pools of Zap70. Full-length Zap70 would not be a good alternative reporter of pLck 
activity as Zap70 diffuses evenly throughout the interface for subsequent signal propagations. 
However, the tandem SH2-domain remains a strong candidate to monitor pITAM state, an 
indirect indicator of pLck kinase activity. 
4.2 Materials and Method 
4.2.1 SH2-ZAP-YPET Plasmid Preparation. 
A custom plasmid was synthesized by Invitrogen via GeneArt. In a pMK-T backbone with 
Kanamycin resistance, AscI and Sfgl flanked 784bp of interest. Both the LckR_FRET reporter and 
the custom plasmid were digested with AscI and SgfI/AsisI (New England Biolab, R0534 and 
R0630). Ligation of the two fragments was performed as previously described. 
The DNA sequence was validated using 5 primers: CTGCTTCTCGCTTCTGTTC, 





Immunostaining were performed in Jurkat cells to study SH2_YPET colocalization. The fixing and 
the immunostainings were performed as previously described. Additional immunostainings 
were done for pZAP20 using antibodies against Zap70 Y319/Syk Y352 (Cell Signaling, 27011). 
4.2.3 Data Acquisition and Analysis for Zap70 Recruitment 
Data acquisition was completed as previously described.  
Before Lck activation, Zap70 is found throughout the cytosol. And upon activation, Zap70 
through its tandem SH2-domain is recruited to the doubly phosphorylated ITAMs, located just 
below the plasma membrane.  To image proteins recruited to the cellular membrane, total 
internal reflection florescence microscopy (TIRFM) is used. TIRFM is spatially restricted by its 
excitation or evanescent field. This is achieved when a laser beam is shined off-axis at an angle 
greater than the critical angle, which is a function of the differences in refractive indices 
between the sample and the cover slip (Snell’s Law). At off-axis angle greater than the critical 
angle, the light beam undergoes total internal reflection, thus reflected back instead of through 
the sample. However, some of the incident energy penetrate to create an evanescent field 
where the intensity decays exponentially (Fig. 4.3B) (Mattheyses, Simon et al. 2010): 
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Where n1 and n2 is the refractive indices of the sample and the coverslide, respectively. 




Figure 4.3: A. In epifluorescence, the light source penetrates the cover slip to illuminate a field of view without 
spatial constraint. B. TIRF imaging, the beam undergoes total internal reflection. Some of the incident energy 
generate an evanescent field. Its depth is a function of the differences in refractive induces of the interface, and 
its intensity decays exponentially. From (Mattheyses, Simon et al. 2010). 
For a standard setup, TIRF penetrates a depth of approximately 100nm. TIRF is able to spatially 
visualize proteins proximal to the plasma membrane; however, with plasma membrane to be 
only about 10nm thick, the technique also captures proteins in the cytosol.  To extract proteins 
being actively recruited to the membrane versus ones in the cytosol, epifluorescence is used. 
Epifluorescence illustrates through the glass cover slip and is not spatially restricted, in the z-
axis (Fig. 4.3A). Thus recruitment is revealed by changes in the ratio of TIRF to epifluorescence 




To map SH2_YPET recruitment as an indicator of pLck kinase activity, background was 
subtracted via MetaMorph. Then TIRF/Epifluorescence (TIRF/EF) ratio was calculated on a pixel-
to-pixel basis.  
4.3 Results 
4.3.1 Designing and Synthesizing the Zap70 Recruitment (SH2_YPET) 
Reporter 
The LckR_FRET reporter already contain the tandem SH2-domain from Zap70. Thus it was 
modified to remove both the Lck targeting domain and the ITAM3. To quantify SH2 (Zap70) 
recruitment, the fluorescent tag must be TIRF compatible (excitable by a 450nm laser), thus 
YPET was selected. Also the fluorescent protein has better quantum yield and extinction 
coefficient than either mCherry or eGFP (Fig. 4.3) (Table 4.1).  
 
Figure 4.4: Schematic of reporter redesign from a pLck FRET reporter to a Zap70 recruitment biosensor.  
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Table 4.1: Sequence for YPET_ SH2 recruitment reporter. 
 
Theoretically, as the SH2_YPET biosensors cycle on and off the pITAMs, phosphatases are able 
to dephosphorylate/deactivate the ITAMs, pLck, and Zap70. Thus the ability of pITAM to 
continue to recruit SH2_YPET is being used as an alternative reporter of pLck kinase activity.  
 -61    GGCGCGC Cagtcctccg acaaTAATAC GACTCACTAT AGGGagacaa gcttcgaatt 
   1 ATGgtgagca aaggcgaaga gctgttcacc ggcgtggtgc ccatcctggt ggagctggac 
  61 ggcgacgtga acggccacaa gttcagcgtg agcggcgagg gcgagggcga cgccacctac 
 121 ggcaagctga ccctgaagct gctgtgcacc accggcaagc tgcccgtgcc ctggcccacc 
 181 ctggtgacca ccctgggcta cggcgtgcag tgcttcgccc ggtaccccga ccacatgaag   
 241  cagcacgact tcttcaagag cgccatgccc gagggctacg tgcaggagcg gaccatcttc 
 301 ttcaaggacg acggcaacta caagacccgg gccgaggtga agttcgaggg cgacaccctg 
 361 gtgaaccgga tcgagctgaa gggcatcgac ttcaaggagg acggcaacat cctgggccac 
 421 aagctggagt acaactacaa cagccacaac gtgtacatca ccgccgacaa gcagaagaac 
 481 ggcatcaagg ccaacttcaa gatccggcac aacatcgagg acggcggcgt gCAGCTGgcc 
 541 gaccactacc agcagaacac ccccatcggc gacggccccg tgctgctgcc cgacaaccac    
 601 tacctgagct accagagcgc cctgttcaag gaccccaacg agaagcggga ccacatggtg  
 661 ctgctggagt tcctgaccgc cgccggcatc accgagggca tgaacgagct ctataagaaG 
 721 CGATCGCacc ggtatacaag tttgtacaaa aaagcaggct ccgcggccgc ccccttcacc 
 781 atgccagacc ccgcggcgca cctgcccttc ttctacggca gcatctcgcg tgccgaggcc 
 847 gaggagcacc tgaagctggc gggcatggcg gacgggctct tcctgctgcg ccagtgcctg  
 901 cgctcgctgg gcggctatgt gctgtcgctc gtgcacgatg tgcgcttcca ccactttccc  
 961 atcgagcgcc agctcaacgg cacctacgcc attgccggcg gcaaagcgca ctgtggaccg  
1021 gcagagctct gcgagttcta ctcgcgcgac cccgacgggc tgccctgcaa cctgcgcaag 
1081 ccgtgcaacc ggccgtcggg cctcgagccg cagccggggg tcttcgactg cctgcgagac  
1141  gccatggtgc gtgactacgt gcgccagacg tggaagctgg agggcgaggc cctggagcag  
1201 gccatcatca gccaggcccc gcaggtggag aagctcattg ctacgacggc ccacgagcgg 
1261 atgccctggt accacagcag cctgacgcgt gaggaggccg agcgcaaact ttactctggg 
1321 gcgcagaccg acggcaagtt cctgctgagg ccgcggaagg agcagggcac atacgccctg 
1381 tccctcatct atgggaagac ggtgtaccac tacctcatca gccaagacaa ggcgggcaag 
1441 tactgcattc ccgagggcac caagtttgac acgctctggc agctggtgga gtatctgaag 
1501 ctgaaggcgg acgggctcat ctactgcctg aaggaggcct gccccaacag cagtgcccca 
1561 gggcaccatc atcatcatca tTAAgcggcc gcgacTCTAG AGTCGACctg caggcatgc 
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The probe reveals the duration of pLck kinase activity associated with CD3/ITAM. However, it 




Figure 4.5: A. SH2_YPET transfected Jurkat cell on surface completely coated with activating antibodies. Clusters 
of ZH2_YPET were laterally static. B. In contrast, SH2_YPET was very fluid in Jurkat cell exposed to SEG 
micropatterns C. The fully coated surface was used to check whether SH2_YPET molecules were stably bound to 
pITAM. Its recovery in about 2 minutes suggested active exchange between bleached and unbleached pools of 




C. T = 0s T = 12s
T = 24s T = 36s T = 48s
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For SH2_YPET to be a dynamic and real-time reporter of pLck activity, it’s important to test 
whether individual molecules are stably bound to pITAM. Jurkats transfected with SH2_YPET 
mRNA were placed on two different surfaces. While the SH2_YPET reporter was very dynamic 
on micropatterned surfaces, especially on SEG patterns (Fig. 4.5B), the reporter was more 
laterally static on fully coated surfaces (Fig. 4.5A). To check for SH2_YPET cycling, FRAP was 
performed to monitor fluorescent recovery. The recovery was nearly complete after 2 minutes 
(Fig. 4.5C). Thus the probes were being rapidly exchanged between bleached and unbleached 
pools of SH2_YPET, allowing for dynamic reporting of pLck kinase activity.  
 
 
Figure 4.6: SH2_YPET distribution is unique from both pZap70 and pLck. Its distribution more closely resembles 
that of pLck than pZap70. While pZap70 has mostly disappeared 15 minutes after seeding, pLck concentrated on 
the micropatterned protein dots with some found throughout the cell. Scale bar = 5µm. 
While the SH2_YPET reporter only contains the tandem SH2-domain from Zap70, studies were 
completed to ensure that it does not diffuse and behave like Zap70. According to Bunnell, 








laterally static. Immunostainings were performed 15 minutes after seeding to study the 
distribution of SH2_YPET versus pLck or pZAP70. The SH2_YPET reporters did not diffuse with 
full-length Zap70 proteins. After 15 minutes, pZAP70 had all but disappeared from the cell. 
Instead, the recruitment probe had a similar distribution as pLck, concentrated on the 
micropatterned protein dots with some proteins found throughout the cell.  
The final plasmid for SH2_YPET was then sequenced.  
  1 MVSKGEELFT GVVPILVELD GDVNGHKFSV SGEGEGDATY GKLTLKLLCT TGKLPVPWPT    
 61 LVTTLGYGVQ CFARYPDHMK QHDFFKSAMP EGYVQERTIF FKDDGNYKTR AEVKFEGDTL 
121 VNRIELKGID FKEDGNILGH KLEYNYNSHN VYITADKQKN GIKANFKIRH NIEDGGVQLA 
181 DHYQQNTPIG DGPVLLPDNH YLSYQSALFK DPNEKRDHMV LLEFLTAAGI TEGMNELYKK 
241 RSHRYTSLYK KAGSAAAPFT MPDPAAHLPF FYGSISRAEA EEHLKLAGMA DGLFLLRQCL 
301 RSLGGYVLSL VHDVRFHHFP IERQLNGTYA IAGGKAHCGP AELCEFYSRD PDGLPCNLRK 
361 PCNRPSGLEP QPGVFDCLRD AMVRDYVRQT WKLEGEALEQ AIISQAPQVE KLIATTAHER 
421 MPWYHSSLTR EEAERKLYSG AQTDGKFLLR PRKEQGTYAL SLIYGKTVYH YLISQDKAGK 
481 YCIPEGTKFD TLWQLVEYLK LKADGLIYCL KEACPNSSAP GHHHHHH 
4.3.2 SH2_YPET Recruitment Reporter Analysis  
Again a large population of cells landed between the micropatterned dots. Without stimulation, 
minimal changes were observed in epifluorescence intensity. And TIRF intensity increased upon 




Figure 4.7: Null cells transfected with SH2_YPET mRNA were seeded on micropatterned surfaces. No intense 
increases in TIRF of SH2_YPET (in green) was observed beyond the initial cell landing and spreading. 
Epifluorescence of SH2_YPET (in red) remained largely unchanged. Scale bar = 5µm. 
SH2_YPET appears to be a more sensitive reporter than LckR_FRET. This was illustrated by 
studies on CD3 only surfaces. Immunostainings revealed pLck colocalizing on -CD3 
micropatterned dots. However, because LckR_FRET has a narrow dynamic range, no heightened 
FRET response was observed in FRET ratio color maps (Fig. 4.8).  
 
Figure 4.8: Jurkat cell transfected with LckR_FRET on α-CD3 (blue) only surface with YPET in green and mCherry in 
red. The FRET reporter was unable to detect a high concentration of kinase activity on the α-CD3 dot as seen in 
the color map.  Scale bar = 5µm. 
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However, the SH2_YPET reporter was able to capture the increased pLck activity on the 
stamped -CD3 dots (Fig. 4.9). Though, the method to quantify SH2_YPET recruitment does 
have its limitations. Specifically, the analysis is spatially sensitive. For example, as the cell lands 
on a stamped protein dot, the epifluorescence intensity starts to increase before the TIRF 
intensity, suggesting active recruitment to the surface. However, when cell continues to spread, 
but only interact with the protein dot at the cell edge, the epifluorescence intensity decreases 
significantly around the dot. This is due to the cell body shifting away from the stamp, possibly 
masking recruitment to the membrane and certainly distorting the recruitment ratio (Fig. 4.9). 
 
Figure 4.9: Jurkat cell transfected with SH2_YPET on α-CD3 (blue) only surface. When a cell only interacts with 
micropatterned surface at the lamellipodia, the recruitment ratio exhibits spatial distortion.  Note the gradient 
in epifluorescence intensity (red) as a function of cell radius. Scale bar = 5µm. 
As previously described, when seeded onto COL surfaces, Jurkat cells settle onto the stamped 
protein dots (Fig. 4.10). An increase in epifluorescence intensity precedes any TIRF intensity, as 
pLck kinase activity increased upon cell landing on the surface. As seen in FRET, pLck was found 
throughout the cell (see T = 2m), with concentrated activity at the stamped protein. While pLck 
activity slowly dropped off across the interface, the recruitment remained strong at the -






Figure 4.10:  Jurkat cell transfected with SH2_YPET (TIRF intensity in green and epifluorescence intensity in red) 
on COL pattern (blue). The cell lands and spreads around the stamped protein. Initially, pLck was found 
throughout the interface, with heightened kinase activity on the -CD3/-CD28 dot. While pLck activity 
gradually dropped off across the interface, recruitment remained strong at the dot. A trace of averaged 
intensities on the dot was plotted. Scale bar = 5µm. 
However, the ratio was still sensitive to SH2_YPET expression level, thus the recruitment ratio 
had to be normalized. When several traces of averaged intensity on -CD3/-CD28 dots were 
overlaid, a characteristic curve arose. Roughly 7.5 minutes after cell landing, the recruitment 
ratio reached its peak and started to slowly decay. The full width at half maximum was roughly 




Figure 4.11: TIRF/Epifluorescence ratio of Jurkat cells on COL surfaces.  
Also as previously described, Jurkat cells are very migratory on SEG patterns. Upon contact with 
-CD3 (T = 0), an increase in pLck kinase activity resulted in a marked rise in SH2_YPET 
recruitment to the center of the cell as the cell continued to move (Fig. 4.12).  
While concentrated region of SH2_YPET recruitment occurred near the center of the cell, the 
recruitment ratio was still spatially distorted. As the cell migrates, its cell body shifted resulting 
in rapid drops in SH2_YPET epifluorescence. Thus, the recruitment ratio lacked a characteristic 
shape.  
 
Figure 4.12: Jurkat cell on SEG pattern (blue for -CD28 and pink for -CD3). As previously discussed, the cell initiated 
contact with -CD3 dot and increased recruitment of reporter was observed near the center of the cell. Scale bar = 10µm. 
Unable to compare recruitment ratios between COL and SEG patterns, the decay of peak TIRF 
intensity examined. If a pattern induced a more sustained pLck kinase activity, the decay should 
be slowed by more SH2_YPET recruitment. Again normalization was performed to account for 
differences in SH2_YPET expression level. Below are traces of averaged intensity for regions of 
concentrated SH2_YPET recruitment. For COL patterns, this colocalized with both the printed -
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CD3/-CD28 protein dot and the center of the cells. For SEG pattern, ROI was often the center 
of the cell. Looking at the signal decay on COL patterns (green curves), the traces were closely 
clustered together and dropped off more slowly. In contrast, SEG dropped off more rapidly (red 
curves). In conclusion pLck kinase activity was more sustained on COL patterns versus SEG 
patterns. 
 
Figure 4.13: Normalized TIRF intensity of Jurkat cells on COL (in green) and SEG (in red) patterns. The decay in 
signal was slower on COL patterns versus SEG patterns. 
4.4 Discussion 
SH2_YPET recruitment reporter was constructed to answer some of questions that arose from 
the LckR_FRET reporter. The FRET plasmid was sufficient at demonstrating the importance of -
CD3 in inducing a spike in pLck activity. Jurkat cells naturally adhere on glass coverslides. And 
without stimulation, pLck kinase activity was observed in Jurkats upon landing and spreading on 
untreated glass surfaces. However, CD3 signal was required for a spike in pLck activity. This was 
demonstrated on SEG patterns, where Jurkat cells land and spread on -CD28 surfaces, and 
only the contact with -CD3 dots, 10 minutes after landing, induced a centripetal retrograde 
flow and a spike in pLck kinase activity. However no differences in FRET ratio were observed 
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between cells on COL and SEG surfaces. Alternatively, the lack of difference could be due to 
biosensor insensitivity; or for the duration in question, the FRET ratios were the same.  
SH2_YPET reporter was designed to study the duration of pLck kinase activity. PLck 
phosphorylates pITAM, which recruits the tandem SH2-domain. As dynamic, real-time reporter 
of pLck kinase activity, SH2_YPET reporter must not be stably bound to the pITAMs. Instead it 
should be rapidly exchanged, allowing for phosphatase to deactivate/dephosphorylate on the 
pITAMs. Photobleaching studies were performed to assess fluorescent recovery. On fully 
coated glass cover slide, pITAM appeared to be laterally static, thus a good surface for the FRAP 
studies. Recovery was observed in about 2 minutes, implying a rapid exchange between 
bleached and unbleached pools of SH2_YPET proteins. 
Close examination of Jurkat cells on various surfaces revealed limitations to the analysis. TIRF 
microscopy while spatially restricted still captured proteins in the cytosol, because despite a 
penetration depth of roughly 100nm, the average thickness of the plasma membrane is only 
10nm.  To visualize active SH2_YPET recruitment, epifluorescence intensity was acquired.  And 
the recruitment ratio was calculated dividing the TIRF intensities by the epifluorescence 
intensities. An increase in ratio signified active recruitment, while decrease described particle 
endocytosis or internalization.  
However, in cells that had spread but was still actively sampling the surrounding areas, the cell 
body/bulk would shift rapidly result in sharp changes in epifluorescence intensity, thus 
distorting the recruitment ratio. And data analysis necessitated comparison between largely 
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immobile and rapidly migrating cells, specifically those exposed to COL and SEG patterns, 
respectively. An alternative analysis was required. Instead of quantifying the recruitment ratio, 
decay of the peak TIRF intensity was measured. If pLck kinase activity was more sustained, 
SH2_YPET would continue to be recruited and retained for a slower signal decay. Comparison 
between traces on both COL and SEG patterns revealed more rapid decay of TIRF intensity in 
cells seeded on SEG patterns. The shorter pLck activation could account for the observed poor 






5. Conclusion and Future 
Directions 
The primary aim of the two reporters was to understand the spatial role of CD28 in T-cell 
modulating T-activation. Motivated by the awesome potential of immunotherapy for cancer 
treatments, this dissertation attempts to understand how spatial cues could be used to modify 
cellular activation for adoptive immunotherapy. 
For Jurkat cells, co-engagement of CD3 and CD28 (as on COL surfaces) was needed to induce 
strong IL-2 secretions, a marker of robust T-cell activation. Previous work in our lab identified 
activated pLck as the intermediary between CD3- and CD28- associate signaling pathways. Lck is 
a well-studied member of the Src family kinases. However many questions remain about the 
protein. At the most basic level, its activation is not well understood. The protein is able to 
autophosphorylate in vitro and a population of activated protein exists before stimulation 
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(Nika, Soldani et al. 2010). However, what is happening during activation to induce pLck kinase 
activity for subsequent signaling cascades? And how is it regulated? Many studies propose 
spatial organization as a means to control pLck activity (Dustin, Chakraborty et al. 2010, Rossy, 
Williamson et al. 2012, Bashour, Tsai et al. 2014). A dynamic, real-time reporter of pLck activity 
was needed.  
Many groups utilize FRET reporters to investigate cellular activities in real-time. A related 
reporter was the biosensor constructed by Stirnweiss and colleagues to study Lck conformation. 
They reported a 20% increase in ‘open’ conformation being recruited to the membrane upon 
activation. However, no information on intracellular Lck kinase activity was available. Thus my 
thesis focused on designing and synthesizing a FRET reporter of pLck kinase activity. 
The Src reporter from Wang and colleagues was studied in constructing the LckR_FRET 
reporter. LckR_FRET reporter exhibited an increase in FRET ratio in response to cellular 
activation. And using micropatterned surfaces, one is able to visualize in real-time, the 
importance of CD3 engagement on heightened pLck activity. However, limitations of the system 
prevented the visualization of differences in FRET ratio between Jurkats seeded on COL 
patterns and those seeded on SEG patterns. The FRET ratio was also sensitive to expression 
level, cellular movement, and photobleaching of the YPET proteins. Guided by IL-2 secretion 
assays, it’s known that CD28 is required for IL-2 secretion. And the spatial organization of CD3 
and CD28 modulates the strength of the activation. IL-2 secretion on COL pattern was ~2.5x 
that of SEG patterns. However, the FRET ratios, averaged from when the cells have completely 
spread to about 15 minutes after landing, were indistinguishable between the two surfaces. 
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Two possible explanations were proposed for the lack of differences in FRET ratios. One, 
because the dynamic range for the FRET reporter was quite narrow, differences in pLck activity 
was masked. Two, while the magnitude of the pLck kinase activity was the same, the duration 
of the activity could be different between the two surfaces.  
Next, a recruitment probe was constructed to study the duration of pLck activity. The ITAMs of 
the CD3 receptors, found throughout the plasma membrane, are well-known targets of pLck 
kinase activity. And pLck-activated pITAMs rapidly recruit tandem SH2-domain of Zap70 to the 
membrane. The SH2_YPET reporter revealed a more sustained pLck activity on COL pattern.  
What remain unaddressed are the differences in pLck kinase activity on the two surfaces, 
immediately after T-cell activation. Beyond a more prolonged pLck activity on COL patterns, 
could the surface induce a stronger spike initially? In another word, is the FRET response larger 
on COL patterns? To answer that question, the LckR_FRET expression level must be better 
controlled.  One approach would be to switch into a lentiviral transduction system for a more 
stable expression of the construct. Also, Jurkats could be sorted by LckR_FRET expression levels 
using FACS. Looking forward into the future, one big question at the system level is the 
mechanism of the observed prolonged pLck activity. How does CD28 mediate the process? 
Could CD28 help to recruit pLck? However, both reporters did not reveal heightened pLck 
activity on CD28 dots in the SEG patterns. And why does the segregation of CD28 engagement 
from CD3 result in more cellular movement and migration? If future studies were able to 
elucidate the relevant pathways, they could be targeted during in vitro T-cell culturing to 
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A. Matlab Codes for Timelapse FRET Analysis 
A.1 FRET_MM_NoMask.m 
The .m file performs cross correlation and FRET ratio calculation on a pixel-to-pixel basis. 
clear; clc; 
  
%%  Pre-treating the data  using MetaMorph%% 
  
% select an area as the background using trace region icon 
  
% BACKGROUND SUBTRACTION 
% Go to 'Process' menu  
% --> Background and Shading Correction...  
% --> select source image  
%     select full stack (subtract background from each image of the 
stack) 
% --> Operation: -> Statistical Correction 
% --> Parameters: -> Region Statistics -> Average -> Region number: 1 
  
% 3X3 MEDIAN FILTER SMOOTHING 
% Go to 'Process' menu  
% --> Basic Filters...  
% --> select 'Statistical Correction' stack  
%     select full stack (smoothing of the whole stack) 
% --> Operation: -> Median 
% --> Parameters: -> filter width: 3 -> filter height: 3 -> sub-sample 
ratio: 1 
  
Donor = 'COL1_1Donor_MF.tif'; 
%%______CHANGE NAME 
Acceptor = 'COL1_1Acceptor_MF.tif'; 
%%______CHANGE NAME 









num_image = max(size(imfinfo(Donor))); 
[YFPcr rect] = imcrop(imadjust(imread(Donor,1))); % YFPcr: adjusted 
image intensity (like in imageJ) 
title('Crop the YFP/Donor image'); 
[isize jsize] = size(YFPcr); 
  





% Initialize variables 
offsets = zeros(num_image,3); 
offsets1 = zeros(num_image,3); 
  
for i=1:num_image 
     
    YFPcrop = imcrop(imread(Donor,i), rect); % YFPcrop: intensity 
unadjusted image 
  
    mFP = imadjust(imread(Acceptor,i)); % Read in the mCherry image as 
the base 
    A = normxcorr2(YFPcrop,mFP); % Template is YFP cropped image, base 
is mCherry 
     
    [max_A, imax] = max(abs(A(:))); 
    [ipeak, jpeak] = ind2sub(size(A),imax(1)); 
    corr_offset1 = [ (ipeak-size(YFPcrop,1)) (jpeak-size(YFPcrop,2)) 
]; % How the template image needs to translate [i distance, j 
distance] 
    offsets(i,1:2) = corr_offset1; 
    offsets(i,3) = max_A; 
    rect_new = [corr_offset1(2)+.51, 
corr_offset1(1)+.51,rect(3),rect(4)]; 
    mFPcrop = imcrop(imread(Acceptor,i), rect_new); % Crop the mCherry 
image unadjusted 
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    % Calculate FRET ratio, mCherry/YFP on a pixel-by-pixel basis 
    FRETratio = (double(mFPcrop) ./ double(YFPcrop)); 
%unadjusted/unadjusted 
    FRETratio(isnan(FRETratio)) = 0; 
    FRETratio(isinf(FRETratio)) = 0; 
     
    % Apply the cell mask to the FRET ratio 
    FRETcell{i} = FRETratio; 
     
    % stamp for later 
    stampCro = imcrop(imadjust(imread(Stamp,i)), rect); 
     i 
     
end 







The .m file generates a heat map from the FRET ratios. And it overlay the stamping on top. 
%%                   Plot figure and set properties                     
%% 
  
cmap  = jet(256); 
cmap(1,:) = [0 0 0] 
bot = 0; 




aviobj = VideoWriter('COL1_1_MF_noCB'); 
%%______CHANGE NAME 
aviobjS = VideoWriter('COL1_1_MF_S'); 
%%______CHANGE NAME 
aviobj.FrameRate = 5; 
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    figure 
    imshow(FRETcell{i},[bot cap],'Colormap',cmap, 'Border', 'tight'); 
    F = getframe; 
    writeVideo(aviobj,F); 
    close 






    figure 
    imshow(stampCro, 'Border', 'tight') 
    G = getframe; 
    writeVideo(aviobjS,G); 
    close 




%% convert avi to tif 
pause 
  
%% superimpose stamp onto FRET image 
  
aviobjO = VideoWriter('COL1_1_MFandS'); 
%%______CHANGE NAME 




    h = figure; 
    bg = imread('COL1_1_noCB.tif',i); 
    %______CHANGE NAME 
    im = imread('COL1_1_MF_S.tif',i); 
    %______CHANGE NAME 
    imshow(bg, 'Border', 'tight'); 
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    hold on 
    iim2 = image(im,'XData',[0 0],'YData',[0 0]); 
    alpha(iim2, 0.15); 
    F = getframe(h); 
    writeVideo(aviobjO,F); 
    i 






The .m file generates an .avi of the FRET ratio heat map with its scale or color bar. 
%%                   Plot figure and set properties                     
%% 
  
cmap  = jet(256); 
cmap(1,:) = [0 0 0] 
bot = 0; 




aviobj = VideoWriter('COL1_1'); 
%%______CHANGE NAME 




    h = figure; 
    imshow(FRETcell{i},[bot cap],'Colormap',cmap), colorbar 
    F = getframe(h); 
    writeVideo(aviobj,F); 
    close 










%%            Define a region of interest for FRET mask             %% 
  
%  Define ROI of the cell body 
figure   
bg2 = imcrop(imadjust(imread(Donor,16)),rect); 
im2 = imcrop(imread(Stamp,1),rect); 
  
  
imshow(bg2, 'Border', 'tight'); 
hold on 
iim2 = image(im2,'XData',[0 0],'YData',[0 0]); 
alpha(iim2, 0.4); 
     
title('Select the CD3 dot') 
[CD3cell xi1body yi1body]=roipoly; 
  
title('Select the CD28 dot') 





     
    % Apply the cell mask to the FRET ratio 
    FRETroiCD3{i} = FRETcell{i}.*CD3cell; 
    FRETroiCD28{i} = FRETcell{i}.*CD28cell; 
    % Calculate the mean FRET in the region of interest 
    FRETmeanCD3(i) = mean2(FRETroiCD3{i}(CD3cell==1)); 
    FRETmeanCD28(i) = mean2(FRETroiCD28{i}(CD28cell==1)); 
  
    % YFP 
    YFPalone{i} = imcrop(imread(Donor,i), rect); %PD 
    YFPvalue = double(YFPalone{i}); 
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    % Apply the mask to the YFP value 
    YFProiCD3{i} = YFPvalue.*CD3cell; 
    YFProiCD28{i} = YFPvalue.*CD28cell; 
    % Calculate the mean YFP in the region of interest 
    YFPmeanCD3(i) = mean2(YFProiCD3{i}(CD3cell==1)); 
    YFPmeanCD28(i) = mean2(YFProiCD28{i}(CD28cell==1)); 
  
    % mCherry 
    mFPalone{i} = imcrop(imread(Acceptor,i), rect_new); %PD 
    mFPvalue = double(mFPalone{i}); 
    % Apply the mask to the mCherry value 
    mFProiCD3{i} = mFPvalue.*CD3cell; 
    mFProiCD28{i} = mFPvalue.*CD28cell; 
    % Calculate the mean mCherry in the region of interest 
    mFPmeanCD3(i) = mean2(mFProiCD3{i}(CD3cell==1)); 
    mFPmeanCD28(i) = mean2(mFProiCD28{i}(CD28cell==1)); 
     
    i 
end 
  
colFRETCD3 = FRETmeanCD3'; 
colFRETCD28 = FRETmeanCD28'; 
  
colYFPCD3 = YFPmeanCD3'; 
colYFPCD28 = YFPmeanCD28'; 
  
colmFPCD3 = mFPmeanCD3'; 
colmFPCD28 = mFPmeanCD28'; 
  
toc % read elapsed time from stopwatch 
 
save('FRET_CD3vCD28.mat') 








t = 0:.5:((num_image-1)*.5); 
subplot(3,1,1) 
[haxes,hline1,hline2] = plotyy(t,[colYFPCD3 colYFPCD28],t, [colmFPCD3 
colmFPCD28]);  
set(hline1(1),'LineStyle','-.','LineWidth',2,'Color','green'); % set 
linewidth and color 
set(hline1(2),'LineStyle','--','LineWidth',2,'Color','green'); % set 
linewidth and color 
set(hline2(1),'LineStyle','-.','LineWidth',2,'Color','red'); % set 
linewidth and color 
set(hline2(2),'LineStyle','--','LineWidth',2,'Color','red'); % set 
linewidth and colorset(haxes(1),'ycolor','k'); % set axis color 
set(haxes(1),'ycolor','g'); % set axis color 
set(haxes(2),'ycolor','r'); % set axis color 
ylabel(haxes(1),'YFP intensity','Color','green','FontSize',15) % left 
y-axis 
ylabel(haxes(2),'mCherry intensity','Color','red','FontSize',15) % 
right y-axis 
xlabel(haxes(1),'Time (min)','FontSize',15) % x-axis 
title('YFP vs mCherry','Fontsize',20) % title 
 
t = 0:30:((num_image-1)*30); 
subplot(3,1,2) 
[haxes,hline1,hline2] = plotyy(t,[colFRETCD3 colFRETCD28],t, 
[colFRETCD3 colFRETCD28]);  
set(hline1(1),'LineStyle','-.','LineWidth',2,'Color','green'); % set 
linewidth and color 
set(hline1(2),'LineStyle','--','LineWidth',2,'Color','green'); % set 
linewidth and color 
set(hline2(1),'LineStyle','-.','LineWidth',2,'Color','blue'); % set 
linewidth and color 
set(hline2(2),'LineStyle','--','LineWidth',2,'Color','blue'); % set 
linewidth and colorset(haxes(1),'ycolor','k'); % set axis color 
set(haxes(1),'ycolor','b','YLim',[0 1]); % set axis color 
set(haxes(2),'ycolor','b','YLim',[0 1]); % set axis color 
ylabel(haxes(1),'FRET ratio','Color','blue','FontSize',15) % left y-
axis 
ylabel(haxes(2),'FRET ratio','Color','blue','FontSize',15) % right y-
axis 
xlabel(haxes(1),'Time (s)','FontSize',15) % x-axis 




B. Matlab Codes for Timelapse Recruitment Analysis 
B.1 Zap70_all.m 
The .m file calculates ratio of TIRF to epifluorescence intensities on a pixel-to-pixel basis. 
clear; clc; 
  
TIRF = 'T3_TIRF.tif'; 
%%______CHANGE NAME 
EPI = 'T3_EPI.tif'; 
%%______CHANGE NAME 
DAPI = 'T3_Stamp.tif'; 
%%______CHANGE NAME 
  
num_image = max(size(imfinfo(TIRF))); 
  
for i=1:num_image 
     
    M{i}= double(imread(TIRF,i)); 
    Mcrop = double(M{i}); 
     
    C{i} = double(imread(EPI,i)); 
    Ccrop = double(C{i}); 
  
    Recruit = Mcrop./Ccrop; 
    Recruit(isnan(Recruit)) = 0; 
    Recruit(isinf(Recruit)) = 0; 
    ReMap{i} = Recruit; 
      














%%            Define a region of interest          %% 
  
  
%  Define ROI of the cell body 
figure   
bg2 = imadjust(imread(TIRF,30)); 
im2 = imadjust(imread(DAPI,1)); 
imshow(bg2, 'Border', 'tight'); 
hold on 
iim2 = image(im2,'XData',[0 0],'YData',[0 0]); 
alpha(iim2, 0.5); 
     
%%% frame with largest cell body 
title('Select the cell body_dot') 
[BWcellD xibodyD yibodyD]=roipoly; 
  
%%% frame with largest cell body 
title('Select the cell body_dot') 





     
    MembraneD{i} = M{i}.*BWcellD; 
    MembraneN{i} = M{i}.*BWcellN; 
    M_meanD(i) = mean2(MembraneD{i}(BWcellD==1)); 
    M_meanN(i) = mean2(MembraneN{i}(BWcellN==1)); 
     
    CytosolD{i} = C{i}.*BWcellD; 
    CytosolN{i} = C{i}.*BWcellN; 
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    C_meanD(i) = mean2(CytosolD{i}(BWcellD==1));   
    C_meanN(i) = mean2(CytosolN{i}(BWcellN==1));    
     
    RecruitD{i} = ReMap{i}.*BWcellD; 
    RecruitN{i} = ReMap{i}.*BWcellN; 
    R_meanD(i) = mean2(RecruitD{i}(BWcellD==1));   
    R_meanN(i) = mean2(RecruitN{i}(BWcellN==1));   
    i 
end 
  
M_meanD = M_meanD'; 
M_meanN = M_meanN'; 
C_meanD = C_meanD'; 
C_meanN = C_meanN'; 
R_meanD = R_meanD'; 
R_meanN = R_meanN'; 
  
figure 
t = 0:.25:((num_image-1)*.25); 
  
subplot(3,2,1) 
[haxes,hline1,hline2] = plotyy(t,M_meanD,t, C_meanD);  
set(hline1,'LineWidth',2,'Color','green'); % set linewidth and color 
set(hline2,'LineWidth',2,'Color','red'); % set linewidth and color 
set(haxes(1),'ycolor','g'); % set axis color 
ylim(haxes(1), [min(M_meanD), max(M_meanD)]); 
set(haxes(2),'ycolor','r'); % set axis color 
ylim(haxes(2), [min(C_meanD), max(C_meanD)]); 
ylabel(haxes(1),'TIRF','Color','green','FontSize',12) % left y-axis 
ylabel(haxes(2),'EPI','Color','red','FontSize',12) % right y-axis 
xlabel(haxes(1),'Time (min)','FontSize',12) % x-axis 
title('Percentage TIRF_D_O_T vs EPI_D_O_T','Fontsize',17) % title 
  
subplot(3,2,2) 
[haxes,hline1,hline2] = plotyy(t,M_meanN,t, C_meanN);  
set(hline1,'LineWidth',2,'Color','green','LineStyle',':'); % set 
linewidth and color 
set(hline2,'LineWidth',2,'Color','red','LineStyle',':'); % set 
linewidth and color 
set(haxes(1),'ycolor','g'); % set axis color 
ylim(haxes(1), [min(M_meanN), max(M_meanN)]); 
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set(haxes(2),'ycolor','r'); % set axis color 
ylim(haxes(2), [min(C_meanN), max(C_meanN)]); 
ylabel(haxes(1),'TIRF','Color','green','FontSize',12) % left y-axis 
ylabel(haxes(2),'EPI','Color','red','FontSize',12) % right y-axis 
xlabel(haxes(1),'Time (min)','FontSize',12) % x-axis 
title('Percentage TIRF_N_O_N_-_D_O_T vs EPI_N_O_N_-
_D_O_T','Fontsize',17) % title 
  
subplot(3,2,3) 
P = plot(t,M_meanD,'g',t,M_meanN,'g'); 
P(1).LineWidth = 2; P(2).LineWidth = 2;  
P(2).LineStyle =':'; 
xlabel('Time (min)','FontSize',12); 
ylabel('TIRF Intensity','FontSize',12) % left y-axis 
ylim([0, max(M_meanD)]); 




P = plot(t,C_meanD,'r',t,C_meanN,'r'); 
P(1).LineWidth = 2; P(2).LineWidth = 2;  
P(2).LineStyle =':'; 
xlabel('Time (min)','FontSize',12); 
ylabel('EPI Intensity','FontSize',12) % left y-axis 




P = plot(t,R_meanD,'b',t,R_meanN,'b'); 
P(1).LineWidth = 2; P(2).LineWidth = 2;  
P(2).LineStyle =':'; 
xlabel('Time (min)','FontSize',12); 
ylabel('TIRF Intensity','FontSize',12) % left y-axis 
ylim([0, max(R_meanD)]); 
title('TIRF/EPI_D_O_T vs TIRF/EPI_N_O_N_-_D_O_T','Fontsize',17) % 
title 
  
save('T3_ROI.mat') 
%%______CHANGE NAME 
